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Abstract 
Attention Deficit Hyperactivity Disorder (ADHD) is a serious disability 
that has been shown to adversely affect cognition, affect, and behavior. Research using 
traditional measures of cognitive functioning, such as intelligence tests has shown that 
children diagnosed with ADHD pelform poorly on cognitive measures of processing 
speed, and on working memory in particular (Kerns, Mclnerney & Wilde, 2001; Weiler, 
Bernstein, Bellinger & Waber, 2000). Mahone, et al. (2003), note that reviews involving 
the Wechsler Scales for children suggest that Full Scale IQ scores (FSIQ) on the WISC-
III average 5 to 6 points lower than scores in the WISC-R. It was hypothesized that 
changes on revised subtests of the WISC-III Performance Scale may place ADHD 
children at a disadvantage if their performance on these subtests is compared to their 
pelformance on analogous WISC-R subtests. Mahone, et al. (2003) theorize that 
increased executive demands resulted in lower FSIQ scores and call for further analysis 
upon future Wechsler revisions. 
Although results are equivocal, research suggests that psychostimulant medication 
may ameliorate ADHD cognitive deficiencies that adversely impact working memory and 
processing speed. Brown and Borden (1989) suggest that stimulant drug improvement 
occurs primarily on rote or simple tasks, but measures emphasizing the processing of 
higher-order information may be less influenced. Barkley (1998) indicates that the 
impact of drugs upon behavior and concentration was most salient, with performance on 
intelligence tests unaffected by medication. However, most of these studies extrapolated 
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IQ scores either from short forms or from several subtests of the Wechsler scales. 
Research using more traditional measures of cognitive functioning (e.g., standardized 
intelligence tests), and focusing on long-term effects of cognitive performance (Gillberg, 
et aI., 1997; Livingston, Mears, Marshall, Gray & Haak, 1996; Mahone, et aI., 2003), 
suggests that results depend on the measures and methods used. 
As part of the initial validation of the revised WISC-IV, an ADHD group was 
compared to a matched control group. Additional research called for investigations 
comparing the performance of medicated ADHD children with nonmedicated ADHD 
children. This research used the Wechsler Intelligence Test for Children-fourth edition 
(WISC-IV) to assess the cognitive performance of medicated ADHD children and 
nonmedicated ADHD children. Results were used to answer the questions: "Are there 
differences in IQ scores between ADHD children and normal controls, and between 
medicated ADHD children and nonmedicated ADHD children?" 
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Chapter 1  
Introduction  
Statement of the Problem 
Attention Deficit/Hyperactivity Disorder (ADHD) is one of the most frequently 
diagnosed disorders in the pediatric population, with an estimated prevalence between 
4% - 12% of all school-aged children (APA, 2000, DSM-IV-TR). ADHD is a serious 
disability with long-term consequences. There is some evidence, albeit equivocal, of 
cognitive impairments in ADHD in terms of response inhibition, working memory, and 
lapses in attention as reflected by variability in response time. Previous studies have 
shown that children diagnosed with ADHD pelform poorly on neuropsychological tests, 
particularly on cognitive measures of processing speed and working memory (Kail, 2000; 
Kail & Salthouse, 1994; Kalff, et al., 2002; Karatekin and Asarnow, 1998). Research 
suggests that Wechsler Intelligence Scale for Children-Revised (WISC-R) scores are 
significantly lower among the ADHD groups than among normal controls (Barkley, 
DuPaul & McMurray, 1990). Research also suggests that children with ADHD are more 
likely to be slower in their intellectual development, manifesting scores that average 7 to 
15 points below those of control groups on standardized intelligence tests (Faraone et al., 
1993). 
ADHD and Cognitive Processes 
Some researchers currently characterize ADHD as a condition involving 
executive control difficulties that adversely impact cognitive processes such as working 
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memory and processing speed (DeFockert, Rees, Frith & Lavie, 2001; Weiler, Bernstein, 
Bellinger & Waber, 2000 and 2002). 
Both working memory and processing speed are cognitive processes that are 
involved to some degree in performance of standardized intelligence tests. Research that 
has examined nonverbal working memory impairments has also demonstrated spatial 
working memory problems (Cornoldi et aI., 2001). For example, the Arithmetic subtest 
of the Wechsler scales involves verbal working memory, and the Coding subtest of the 
Wechsler scales is a measure of processing speed, which involves nonverbal working 
memory. Processing speed also factors into performance on Wechsler subtests such as 
the Block Design, Object Assembly and Picture Arrangement (Wechsler, 1991). 
Karatekin and Asarnow (1998) used the Digit Span subtest of the WISC-III to 
investigate verbal working memory in participants with childhood onset schizophrenia, 
attention deficit hyperactivity disorder, and age-matched controls. Results showed that 
normal children recalled more digits than schizophrenic children and ADHD children, 
who did not differ in level of performance. Tiholov, Zawallich and Janzen (1996) found 
that processing speed, as measured by the WISC-III Processing Speed Index (PSI) was a 
significant diagnostic factor differentiating between clinical groups composed of ADHD 
and other diagnoses. 
The recent revision of the Wechsler scales for children, the Wechsler Intelligence 
Scale Fourth Edition (WISC-IV) has placed greater emphasis on working memory and 
processing speed as measures of general intellectual functioning. This could have far 
reaching implications for the intelligence assessment of ADHD children's cognitive 
capabilities. It is very possible that intelligence quotients (IQ's) of ADHD children could 
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be even more negatively impacted. For example, the name change from Perceptual 
Organization Index (POI) in WISC-III to Perceptual Reasoning Index (PRI) in WISC-IV 
reflects the increased emphasis on fluid reasoning abilities in this index (Wechsler, 2003). 
Speed of processing continues to contribute to time bonuses in the Block Design (BD) 
subtest. Although BD may be scored with and without time bonuses, only the score with 
time bonuses is used in the calculation of PRI and Full Scale Intelligence Quotient 
(FSIQ). The comparison of Block Design with time bonuses versus BDN (no time 
bonus) gives information about the effect of speed on pelformance. Working memory is 
a factor for successful pelformance on PRI subtests such as Picture Concepts. Picture 
Concepts appears to measure abstract, categorical reasoning based on perceptual 
recognition processes (Sattler& Dumont, 2004). The child must initially recognize or 
identify each picture and then determine a quality that a picture in one row shares with a 
picture in another row. Therefore, the child needs to rely on stored information while 
using fluid reasoning. The Matrix Reasoning subtest involves perceptual reasoning 
ability without a speed component. Despite good reasoning and organizational ability, 
impulsive responding and poor attention to detail, as well as spatial working memory 
problems may result in low scores on this and other PRI subtests. 
ADHD, Cognitive Processes and Medication Use 
In the US, medication is the most commonly reported form of intervention fOl: 
children with ADHD; about 80 percent of the 11 million prescriptions written for 
methylphenidate each year are written for children (Purdie, Hattie, & Carroll, 2002). 
Given that many ADHD children receive psychopharmacological treatment, the fact that 
treated samples show neuropsychological deficits is relevant to many clinicians and 
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educators. Consumers of psychological services would also be interested in knowing if 
psychostimulants enhance cognitive performance on intelligence tests. 
Doyle, et a1. (2000) noted that further study of ADHD persons before and after the use of 
stimulant and other medications is necessary to determine the impact of medications on 
test sensitivity. Few studies have used full-scale tests of intelligence to measure 
medication effects. 
A controversial issue related to the treatment of Attention Deficit Hyperactivity 
Disorder involves the use of psychostimulant medication in the pediatric population. 
Safer, Zito, & Fine (1996) estimated that l.5 million children annually, or 2.8% of the 
school-aged population may be using stimulants for behavior management. Barkley 
(2006) posited the idea that the impact of drugs upon behavior and concentration was 
most salient, with performance on intelligence tests less affected by medication. Research 
has consistently shown that psychostimulants have positive effects on hyperactivity, 
attention, concentration, and classroom behavior. Short-term positive drug effects are 
shown on measures of neurocognitive abilities such as vigilance, fine-motor coordination, 
and reaction time. However, research using more traditional measures of cognitive 
functioning (e.g. intelligence and achievement tests), and focusing on long-term 
improvement are equivocal (Livingston, Mears, Marshall, Gray & Haak, 1996; Mahone, 
et aI., 2003). Livingston, et al. (1996) found that that medicated and nonmedicated 
children and adolescents with ADHD displayed a similar pattern of intellectual 
peIiormance; however, Mahone, et al. (2003) found that the ADHD group performed 
more poorly on the WISC-Ill than on the WISC-R. Results of a long term, placebo-
controlled study of the stimulant amphetamine in the treatment of ADHD indicates that 
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there are remaining positive effects of the drug 15 months after starting treatment 
(Gillberg, et aI., 1997). Their results indicated that an amphetamine was clearly superior 
to a placebo in reducing inattention, hyperactivity, and other disruptive behaviors; it also 
tended to lead to improved results on the WISC-R. Although academic peIformance and 
intelligence were not measured in this study, the Multimodal Treatment Study of 
Children with ADHD that assessed specific treatment modalities in 579 children, aged 7-
9.9 years with ADHD, Combined Type, clearly demonstrated the benefits of 
pharmacotherapy in ADHD children for a sustained period (The MTA Cooperative 
Group, 1999). 
Previous research has shown that as processing speed, and/or working memory 
demands are increased on the Wechsler scales, the IQ's of ADHD students decrease 
(Zimmerman & Woo-Sam, 1997). Mahone et aI. (2003) noted, in a comparison of the 
WISC-III with the WISC-R, that increased demand for rapid performance in scoring 
procedures of the WISC-III may have inadvertently placed a higher demand on executive 
control functions of ADHD children, placing this group at a particular disadvantage. The 
WISC-IV's demands for further increase in processing speed and working memory have 
implications for the cognitive performance of ADHD children. Little empirical 
information is available contrasting performance of ADHD children, treated or untreated, 
with a normative sample on full-scale tests of intelligence. 
As part of the initial validation of the revised edition, the WISC-IV was 
administered to 89 children aged 8-13 who were identified as having ADHD according to 
DSM-IV -TR diagnostic criteria. Approximately 64% of the children in the ADHD group 
were taking medication for ADHD symptomology at the time of testing. Results were 
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not reported separately by medication status (medicated/nonmedicated). Compared to a 
matched control sample, the group means difference for the PSI reflected a moderate 
effect size. Small effect sizes were reported between the Verbal Comprehension Index 
(VCI), Working Memory Index (WMI), and Full Scale Intelligence Score (FSIQ). At the 
subtest level, the largest effect sizes for group mean scaled score differences were 
reported for the Coding and Arithmetic subtests. The other sub tests that measured 
working memory and processing speed had modest or small effect sizes. These findings 
are somewhat inconsistent with the research literature that suggests significant impact of 
ADHD symptomatology on children's ability to perform working memory and 
processing speed tasks. One reason for this inconsistency may be the lack of separation 
of the ADHD sample into two groups, medicated and nonmedicated. It is possible that 
medicated ADHD children had significantly higher scores on all processing speed and 
working memory tests relative to nonmedicated ADHD children. 
Because the literature lacks clarity in comparing the effect of medication on 
ADHD children's' IQ scores, further research is needed. Another question that needs to 
be answered is whether or not medication improves IQ scores. The present study was 
instigated by the interest in investigating the issues of ADHD and the effects of 
medication on cognitive processes in the context of the latest revision of the Wechsler 
scales. The WISC-IV is a valid and reliable. instrument with sufficient test sensitivity to 
measure the processing demands of working memory and processing speed, as well as the 
effects of medication on intelligence test scores. 
Because of the change in content and structure of the WISC-IV, and a greater 
reliance on working memory and processing speed for successful pelformance, it is very 
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possible that the IQ's of ADHD children could be negatively impacted. Additional 
research is needed comparing the peIformance of medicated and nonmedicated ADHD 
children on the WISC-IV. 
Purpose of the Study 
The major purpose of this study is twofold: . (1) to determine if ADHD affects the 
cognitive processes of working memory and processing speed, and general intellectual 
functioning estimates when these cognitive processes are included as measures of ability; 
and, (2) to determine what effect, if any, the use of medication in children with ADHD 
has on the cognitive processes of working memory, processing speed, and estimates of 
general intellectual functioning. 
Theoretical Background/Related Research 
Definition ofADHD 
The chief features of an Attention Deficit Hyperactivity Disorder (ADHD) are 
inattention, hyperactivity, and impulsiveness. Current guidelines from the American 
Academy of Child and Adolescent Psychiatry and the American Academy of Pediatrics 
recommend that a diagnosis of ADHD in children be established based on the criteria 
defined by the American Psychiatric Association in the Diagnostic and Statistical Manual 
of Mental Disorders, 4th edition (APA, 2000(DSM-IV). DSM-IV is a clinical definition 
that specifies symptoms to be met. These include 6 of 9 symptoms either of inattention 
or of hyperactivity/impulsivity that had been present before age 7, persists for at least 6 
months, is more frequent and severe than is typical for children at comparable ages, 
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manifest in multiple settings, and adversely affects functioning (APA, 2000). The DSM-
JV-TR (2000) now recognizes three subtypes of ADHD. The three categories of ADHD 
are Predominately Inattentive Type (ADHDIIT), Predominately Hyperactive-Impulsive 
Type (ADHD/HIT), and Combined Type (ADHD/CT). 
Power and DuPaul (1996) acknowledged that the DSM-JV definition of ADHD 
reflects important changes in our knowledge of ADHD, but fails to account for important 
changes in attention and hyperactivity-impulsivity that occur during the course of 
development, such as the reduction of hyperactive symptoms. 
Wu, Anderson and Castiello (2002) used measures that allowed the isolation of 
effect associated with lower level abilities (e.g. speed of processing) when a specific 
higher-level cognitive component was examined. They compared their findings with the 
predictions of two major models for ADHD, the resource allocation model (which posits 
that ADHD is associated with problems in utilizing attentional capabilities in an optimal 
manner, but is not associated with attentional incapabilities), and the executive functions 
model (interrelated functions responsible for goal-directed behavior). Results suggested 
that ADHD may be associated with deficits in speed of processing for verbal response 
and sustained attention. Wu, et a1. note that the inhibition and executive dysfunction 
models, which describe fast and impulsive responses for ADHD children, have great 
difficulty explaining slow speed of processing tapped in their study. They suggest that 
ADHD is associated with a state regulation deficit, rather than real limitations of 
attentional or executive capabilities. 
Recent advancements in medical technology have led to refined causal 
explanatory hypotheses of ADHD, implicating dysfunction in the prefrontal-striatal 
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network and brain volume abnormalities that sub serve executive functions and self-
control (Barkley, 1998; Castellanos, et a1., 2002). These findings have been incorporated 
into recent theories of ADHD, including the working memory model of Rapport and 
colleagues (Rapport et aI., 2000; Rapport et aI., 2001), and the disinhibition model of 
Barkley (Barkley (1997a, 1997b). ADHD is currently characterized as a condition 
involving executive control difficulties that adversely impacts cognitive processes such as 
working memory and processing speed. Barkley (2006) noted the utility of the 
descriptive approach to diagnose ADHD as delineated in the DSM-N, but found it 
unable to account for the many cognitive and behavioral deficits that have emerged in 
earlier studies of ADHD (Barkley, DuPaul & McMurray, 1990; Barkley, Grodzinsky & 
DuPaul, 1992), and more recently (Barkley, Murphy & Busch, 2001; Mahone, et aI., 
2002; Rucklidge & Tannock, 2001; Warner-Rogers, Taylor, Taylor & Sandberg, 2000). 
Prevalence ofADHD 
ADHD is the most common neurobehavioral disorder in children, estimated to 
affect between 4% and 12% of all school-aged children (APA, 2000). Rowland, Lesesne 
& Abramowitz (2002) judged that prevalence estimates of ADHD in school-aged 
children ranged between 2% to 18% in community samples. Prevalence estimates vary by 
method of ascertainment, diagnostic system, measures used, informants, and the 
population cited. There has been a rapid rise in prevalence rates of ADHD (Purdie, Hattie 
& Carroll, 2002). A study by Robison, Sclar, Skaer and Galin (1999) found that this 
increase in diagnosis was matched with a 2.9-fold increase in the number of ADHD 
individuals prescribed stimulant medication. A 2003 United States National Survey of 
Children's Health (NSCH) reported that approximately 4.4 million children (7.8%) aged 
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5-17 years have been diagnosed with ADHD; of these, 2.5 million (56%) were reported 
to be taking medication for the disorder. An estimated 4.3% of children aged 4-17 years 
were reported to have had an ADHD diagnosis, and were taking medication for the 
disorder. Prevalence of reported ADHD increased with age, and was significantly lower 
among children aged 4-8 years, compared with children greater than 9 years (NSCH, 
2003). In the 2003 US study, rates of medication treatment varied by age and sex, 
ranging from 0.3% to 9.3%. Regardless of sex, overall medication by age patterns were 
curvilinear, with prevalence of medication highest among children aged 9-13 years, 
compared with younger or older children. 
Gender and ethnic disparities exist in study findings concerning diagnosis and 
treatment of ADHD. Differences between boys and girls identified as ADHD is 
generally under researched. Gaub and Carlson (1997) reviewed 18 studies examining 
gender differences in ADHD and found that the ratio of male to female prevalence of 
ADHD is 3: 1 in community samples, and between 6: 1 and 9: 1 in clinic-referred samples. 
Rates of treatment for ADHD followed the same pattern noted for diagnosis; this means 
that males of all ages were more likely to have a history of diagnosis and to take 
medication for the disorder. Males aged 16 years had the greatest prevalence of ADHD 
diagnosis followed by females aged 11 years (NSCH, 2003). 
Studies of females found that ADHD girls, relative to ADHD boys, showed lower 
levels of hyperactivity, fewer conduct disorder diagnoses, and lower rates of other 
externalizing behavior, but showed greater intellectual impairment (Biederman, et a!., 
1999; Gaub & Carlson, 1997). More recently, Hartung, et a!. (2002) found that boys and 
girls ages 3 to 7 years diagnosed with ADHD did not differ on many factors, including 
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internalizing symptoms, academic achievement, subtype prevalence, and cognitive 
abilities. Their results suggest that the differential referral rates of boys, which is greater 
than girls at this age, is likely due to the higher prevalence of disruptive behavior in boys. 
NSCH (2003) found prevalence of ADHD diagnosis in the United States to be 
significantly higher among non-Hispanic, primarily English speaking, and insured 
children. Prevalence rates were significantly higher in families in which the most highly 
educated adult was a high school graduate (or had completed 12 years of education), 
compared with children in families in which the most highly educated adult had a higher 
or lower level of education (NSCH, 2003). Kendall and Hatton (2002) noted that 
prevalence rates of ADHD among nonwhite, American ethnic minority groups have not 
been established, and the prevalence rates that do exist rarely report the racial 
representation of their sample. Findings of several international cross-cultural studies 
(Anderson, Williams, McGee & Silva, 1987; Brewis, Schmidt & Meyer, 2001) indicated 
that ADHD exists worldwide, with international prevalence rates similar to US rates. 
Kendall and Hatton noted that little research has been conducted to describe ADHD in 
ethnic and racial groups. Instead, ADHD as a diagnosis has been characterized as a 
primarily white, middle class disease, because the majority of the research generated on 
this disorder has been based almost exclusively on this population. Kendall and Hatton 
suggest that this is due to underlying racist assumptions. They posit the theory that 
studies eliminating race as a research variable, in favor of ethnicity as a variable, divert 
attention from the root cause of health disparity, which they believe is inequality and 
discrimination. In order to eliminate health disparities, Kendall and Hatton see the need 
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for researchers to adopt a viewpoint of multiculturalism that acknowledges the cultural 
context of all health processes. 
Cognitive Processes Cllld ADHD 
Some contemporary research has focused on the lower cortical cognitive deficits 
of working memory and processing speed as it is affected by ADHD (DeFockert, Rees, 
Frith & Lavie, 2001; Weiler, Bernstein, Bellinger & Waber, 2000 and 2002). In contrast 
to the clinical view that ADHD is primarily an attention deficit (APA, 2000), and is 
descriptive in nature, some researchers think that ADHD is a condition involving 
executive function deficits that results in specific cognitive difficulties. Barkley (1998) 
theorized that ADHD comprises a deficit in behavioral inhibition that is linked to 
executive neuropsychological abilities such as working memory and processing speed. 
Working memory is defined as the ability to retain, associate, and manipulate on-
line memory storage over a brief time period. Working memory is the ability to actively 
maintain information in conscious awareness, pelform some operation or manipulation 
with it, and produce a result (Wechsler, 2003). Studies such as Fry and Hale (1996), and 
Perlow, Jettuso and Moore (1997), have shown that working memory is an essential 
component of fluid reasoning and other higher order cognitive processes, and is closely 
related to achievement and learning. The more recent interpretation of working memory 
describes it as crucial in the ability to focus. DeFockert, et al. (2001) reported that the 
greater the working memory load, the more will an individual be distracted by irrelevant 
information. They proposed either that impairment in working memory give rise to 
distractibility, or that the opposite occurs. Rapport et al. (2000, 2001) argued that 
working memory is the core deficit in ADHD. The impulsivity, distractibility and 
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disinhibition associated with ADHD is said to be the result of deficiencies in working 
memory. 
Many studies show that ADHD children have deficits in working memory, and in 
short-term memory relative to children without the disorder (Kempton et a!., 1999; 
McInerney & Kerns, 2003; Moore, 2002; Muir-Broaddus, Rosenstein, Medina & 
Soderberg, 2002; Rapport et a!. 2000, 2001; Quinlan & Brown, 2003; West, Houghton, 
Douglas & Whiting, 2002). Karatekin and Asarnow (1998) investigated verbal and 
spatial working memory in participants with childhood onset schizophrenia, attention-
deficit/hyperactivity disorder, and age-matched controls. Using the Digit Span subtest of 
the Wechlser Intelligence Scale for Children-3 rd Edition (WISC-III) for verbal working 
memory, results showed that normal children recalled more digits than schizophrenic 
children and ADHD children, who did not differ. Both schizophrenic and ADHD 
children showed deficits in verbal and spatial working memory. A prospective study 
examined whether or not neurocognitive pelformance of five and six year old children 
later diagnosed with ADHD could contribute to early identification of ADHD. This 
study found that children who were rated as ADHD were, 18 months later, significantly 
impaired on measures of visuomotor ability and working memory, compared to children 
without ADHD (Kalff, et aI., 2002). 
Martinussen, Hayden, Hogg-Johnson and Tannock (2005) located and analyzed 
26 studies published from 1997 through 2003 that examined at least one of four domains 
of working memory (WM) in children 4-18 years old with an IQ greater than 70, and 
with ADHD according to DSM (fourth edition or third edition criteria). Non-English 
language publications were excluded from the review. A separate meta-analysis was 
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pelformed on each WM domain: verbal and spatial storage, and verbal and spatial central 
executive function. The studies varied in their controls for potential confounds, such as 
co-morbid language, learning, anxiety, or oppositional-defiant disorders. The majority of 
the studies had subjects discontinue medication at least 24 hours before testing, but two 
studies did not address medication status. The meta-analyses indicated moderate-to-Iarge 
WM impairment associated with ADHD in all domains, spatial more than verbal. A test 
for publication bias was positive only for studies of verbal storage, indicating that 
negative studies of this domain were less likely to be published. A sensitivity analysis 
found that when one study of verbal central executive function, which used a 
questionable test was removed, the pooled effect size decreased. The meta-analysis 
included a relatively small number of studies, especially in the spatial domains. 
Therefore, the authors stated that findings should be interpreted with caution, and 
considered exploratory in nature. Nonetheless, it was noted that WM deficits 
theoretically mesh with research implicating fronto striatal, and dopamine-system 
dysfunction in ADHD. Martinussen, et al. speculated that WM deficits may explain 
some of the academic difficulties of children with ADHD. In other words, inattention 
alone may not fully explain the learning problems that ADHD children experience, both 
in the classroom and at home. 
Kail (2000) and Kail and Salthouse (1994) have shown that the speed of 
information processing is dynamically related to mental capacity, reasoning by the 
conservation of cognitive resources, and the efficient use of working memory for higher 
order fluid tasks. Donders (1997) showed that processing speed is sensitive to such 
neurological conditions as epilepsy, ADHD, and traumatic brain injury. Kail and 
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Salthouse (l994) noted that it might be especially important to assess processing speed in 
children, because of its relationship to neurological development. They noted that 
clinical research in developmental cognitive neuropsychology suggests a dynamic 
relationship between working memory, processing speed, and reasoning. For example, 
more rapid processing of information may reduce demands on working memory, and 
facilitate reasoning. This has implications for performance on tests of intelligence. 
Tiholov, Zawallich and Janzen (1996) found that processing speed, as measured 
by the WISC-III Processing Speed Index (PSI), was a significant diagnostic factor 
differentiating between clinical groups composed of ADHD, and other diagnoses. 
Prifitera and Dersh (1993) found that their heterogeneous ADHD samples obtained 
scores on the Freedom from Distractibility (FFD) and Processing Speed (PS) factors that 
were within 2 points of each other, suggesting possible impairments in the abilities 
measured by both of these factors. Relative to their Perceptual Organization Index (POI) 
scores, scores on the FFD and PS Indices were approximately 2/3 standard deviation 
lower. 
In examining the neuropsychological profiles of children with ADHD-IT, and 
children with reading disability, Weiler, Bernstein, Bellinger & Waber (2000) found that 
children in the former group were more likely to demonstrate poor pelformance on the 
Coding and Symbol Search task, whereas those with reading disability were 
distinguishable by their poor pelformance on written language measures. Weiler, 
Bernstein, Bellinger & Waber (2002) found that children with ADHD were not globally 
poor at information processing, neither were they inattentive, but they demonstrated 
diminished speed of visual processing. Borger & van der Meere (2000) found that 
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looking away behavior was not .associated with the slower reaction times of ADHD 
children. Looking away behavior had a negative effect on the accuracy of test 
performance of ADHD children only when stimuli were unpredictable. Borger and van 
der Meere concluded that the often-reported slowness of ADHD children is not to be 
explained by their visual behavior. Ruckledge & Tannock (2002) found that an ADHD 
diagnosis, with or without a Reading Disability (RD), was associated with slower 
processing speed and naming of objects, poor behavioral inhibition, and greater 
variability in reaction times. RD (with or without ADHD) was associated with problems 
in verbal working memory, and with slower verbal retrieval speed. ADHD/RD was 
additionally associated with slower naming of numbers and colors, and slower overall 
reaction times. No gender differences were evident on any measures. Ruckledge and 
Tannock concluded that behavior inhibition might not be as central to ADHD deficits as 
other neuropsychological indicators. 
IQ Tests and Effect of Content 071 ADHD Test Scores 
For most intelligence tests in use today, Intelligence Quotient (IQ) Scores are 
derived from a composite of tasks that measure different aspects of cognition. The Full 
Scale IQ (FSIQ) of the Wechlser Intelligence Scale for Children-3rd Edition (WISC-ill) is 
derived from four index scores, the Verbal Comprehension Index (VCI), Perceptual 
Organization Index (POI), Processing Speed Index (PSI), and Freedom from 
Distractibility Index (FFD). These index scores are derived from tasks that measure four 
different types of cognition: verbal abilities, nonverbal abilities, processing speed, and 
working memory, respectively. 
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The effects of ADHD on IQ can be greatly influenced by the nature of the 
cognitive tasks used to assess intelligence. Several researchers have examined the 
predictive or discriminant validity of the WISC-III with respect to ADHD. When studies 
examine differences in patterns of cognitive functioning (Mealer, Morgan & Luscomb, 
1996; Snow & Snap, 2000), results support the diagnostic utility of WISC-III subtest 
profile patterns for ADHD children. Assesmany, McIntosh, Phelps and Rizza (2001) 
explored the ability of the WISC-III to discriminate between ADHD and a group of non-
ADHD children. They also sought to identify which combinations of WISC-III subtests 
resulted in the highest level of correct classifications. A stepwise discriminant function 
analysis indicated that four WISC-III subtests contributed significantly to the prediction 
of group membership: Digit Span, Information, Vocabulary, and Picture Completion. 
An overall classification rate of approximately 39% was attained when the four WISC-III 
subtests were included in the equation. Approximately 90% of the children classified as 
ADHD, and 17.5% of the non-ADHD children were correctly identified when using the 
four WISC-III subtests as predictors. Perugini et al. (2000) examined the predictive 
power of combined neuropsychological measures for ADHD in children. Among other 
measures, the Arithmetic and Digit Span subtests of the WISC-III were administered. 
Group differences were significant on the Digit Span, and continuous performance tests 
only; however, although these two tests provided the strongest prediction, it was modest 
and offered limited diagnostic utility. 
In order to evaluate auditory working memory processes in children with ADHD, 
numerous researchers have also used the WIC-III tasks subsumed under the FFD index. 
Mayes, Calhoun and Crowell (1999) analyzed the WISC-III data in clinical samples of 
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ADHD children, and normally developing children. The mean FSIQ exceeded the FFD 
at all ages in the ADHD group, but not in the non-ADHD group. Further, the 
discrepancy between the FSIQ and FFD was significantly greater in the ADHD group. 
The four lowest mean subtest scores for the ADHD group were: Digit Span, Arithmetic, 
Coding, and Symbol Search. This differed from the results for the non-ADHD group. 
For significantly more children with ADHD (87%), the score for the FFD, plus the PSI, 
was less than the sum of the two remaining index scores. Twenty-three percent of the 
ADHD children, and none of the non-ADHD group had Digit Span and Arithmetic as 
two of their three lowest subtests scores. Krane and Tannock (2001) examined the 
WISC-III FFD factor in the diagnosis of ADHD, including the contribution of behavioral, 
academic, and language variables to the factor. The WISC-ill FDD subtests, along with 
subtests from the WRAT-3, the Woodcock Reading Mastery test-Revised, and the 
Clinical Evaluation of Language Fundamentals, were given to 275 children with ADHD. 
In contrast to the studies that advocated the diagnostic utility of the FFD index in ADHD, 
results from their study showed that a child's FFD score was not a valid diagnostic 
indicator either of ADHD, or of a sUbtype of ADHD. FFD scores were associated 
primarily with arithmetic and receptive language scores, implicating working memory. 
The researchers argue that low FFD scores may signal learning problems, particularly 
with arithmetic, language, and working memory that may contribute to poor academic 
performance. Similarly, Reinecke, Beebe and Stein (1999) found that despite 
significantly lower FFD scores relative to the other WISC-III factor scores of ADHD 
children, the vast majority of ADHD children did not show a significantly relative 
weakness on this index. 
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Research has also indicated that ADHD appears to affect overall level of 
performance on Intelligence Tests (IQ Tests). Although IQ's of children with ADHD 
appear to be normally distributed (Kaplan, et aI., 2000), research suggests that IQ's are 
lower in children with ADHD (Barkley, 1990; Faraone, et aI., 1993; Tripp, Ryan & 
Peace, 2002; Zhuang, Liu & Zhang, 2001). According to Barkley (1998), the experiences 
that ADHD children have with impairments in behavioral inhibition, and the executive 
functions dependent on it, could be expected to result in a small but significant and 
negative relationship between ADHD and IQ, particularly verbal IQ. Psychiatric 
comorbidity complicates cognitive studies of ADHD; however, studies of comorbid 
ADHD children suggest that some intellectual impairment is a core feature of ADHD 
syndrome (Barkley, et aI., 1990; Faraone, et aI., 1993). 
Recent research suggests that revisions of the Wechsler Scales, with its greater 
emphasis on working memory and processing speed (subdomains which are most 
affected by ADHD), might adversely impact IQ scores of ADHD children (Barkley, 
2000; Mahone, et aI., 2003). 
Mahone, et a1. (2003) noted that reviews involving the Wechsler Scales for 
children suggest that Full Scale IQ scores on the WISC-III (Wechsler, 1991) average 5 to 
6 points lower than scores on the Wechlser Intelligence Scale for Children-Revised 
(WISC-R)(Wechsler, 1974), with differences distributed disproportionately over subtests, 
i.e., with larger discrepancies found within the Performance Scale. Mahone, et al. (2003) 
hypothesized that changes on revised subtests of the WISC-III Pelformance Scale may 
place children with ADHD at a disadvantage when compared to their performances on 
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analogous WISC-R subtests. They theorized that increased executive demands resulted in. 
lower FSIQ scores, and called for further analysis upon future Wechsler revisions. 
In their study, Mahone, et al. (2003) examined IQ test peliormance in 122 
unmedicated children with ADHD (61 given the WISC-R, 61 given the WISC-III), and 
46 children from a healthy comparison group (23 given the WISC-R, 23 given the WISC-
III). The ADHD and the comparison group samples were matched for gender and for 
Verbal IQ between WISC-R and WISC-III. Children with ADHD had significantly 
lower Performance IQ's on WISC-III, compared to their performance on the WISC-R, 
with the Picture Arrangement subtest showing the most significant difference. They 
found group differences not only among subtests comprising the Freedom from 
Distractibility and Processing Speed Indices, but also on subtests comprising the Verbal 
Comprehension and Perceptual Organization Indices. Their findings suggested that 
children with ADHD may be vulnerable on multiple aspects of the Wechsler Scales, not 
only on those known to be associated with working memory or inhibitory control. In 
contrast, there were no significant differences between the WISC-R and WISC-III 
cohorts on Performance IQ, or any pelformance subtests among the comparison group. 
Mahone, et al. (2003) findings are said to lend support to the notion that small 
subtest score differences can be expected in unmedicated children with ADHD. They 
stated that parameter changes in WISC-III increase demands for executive control, such 
as speed and accuracy, as well as a higher demand for precision. Horn-Alsberge (1999) 
found that the WISC-III yielded an FSIQ approximately 6 points lower than the WISC-R 
among clinical samples composed of children with learning disabilities, ADHD, and 
affective disorders. VIQ and PIQ on the WISC-III were also approximately 5 points 
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lower than those obtained on the WISC-R. Barkley (2000) also argued that the WISC-III 
verbal subtests, particularly those comprising the Freedom from Distractibility (FFD) 
Index, might place children with ADHD at a particular disadvantage because they assess 
working memory. Mahone, et a1. (2003) cautioned that executive control demands of 
subtests of the next revision of the Wechsler Scales should be examined. 
These findings related to lower WISC scores of ADHD children are not 
surprising, considering the fact that some of the tasks that make up the Wechsler Scales 
require the use of working memory and processing speed for effective performance. If 
ADHD children were indeed weaker in these cognitive functions, then it would be likely 
that their scores on the WISC-R and WISC-III would be somewhat lower than children of 
comparable backgrounds without ADHD. 
Given the literature that suggests that the cognitive performance of children with 
ADHD is adversely affected by the processing demands of working memory and 
processing speed, the emphasis of these abilities on intelligence tests would have great 
impact on test scores of children diagnosed with ADHD. Schwean, Saklofske, Yackulic 
and Quinn (1993) reported on a discriminant validity study of the WISC-III and 45 
clinically referred ADHD children, in ,which intercorrelations between subtests, index 
scores, and IQ's were examined. Findings revealed that the patterns of correlation for the 
ADHD sample were similar to those reported in the WISC-III standardization sample 
across parallel age groups. Profitera, Sakolofske and Wiess (2005) contend that these 
results indicate that the WISC-III is a highly robust measure that retains it characteristics 
when used in an examination of children with ADHD. Given that the WISC-IV 
maintains many of the same subtests, and similar factor structure, Profitera et a1. suggest 
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that, like its predecessor, the WISC-IV will prove to be a psychometrically sound 
instrument applicable for use in assessing ADHD children. 
The most recent revision of the Wechsler Intelligence Scales, the Wechlser 
Intelligence Scale for Children, Fourth Edition (WISC-IV) has enhanced the measure of 
more discrete domains of cognitive functioning (e.g., processing speed, working 
memory), yet continue to provide a reliable measure of global intelligence (i.e. FSIQ). 
The dual IQ (Verbal and Performance) and index score structure implemented in the 
WISC-I1J is no longer utilized. The WISC-IV provides composite or index scores that 
represent intellectual functioning in specified cognitive domains, as well as providing a 
composite score that represents a child's general intellectual ability (i.e., FSIQ). The four 
index scores are: the Verbal Comprehension index (VCl), Perceptual Reasoning Index 
(PRI), Working Memory Index (WMI), and the Processing Speed Index (PSI). The VCI 
is composed of subtests measuring verbal abilities utilizing reasoning, comprehension, 
and conceptualization. The PRI is composed of subtests measuring perceptual reasoning 
and organization. The WMI is composed of subtests measuring attention, concentration, 
and working memory; and, the PSI is composed of sub tests measuring the speed of 
mental and graphomotor processing. 
The WISC-IV reflects the current status of intelligence theory that recognizes that 
intelligence is composed of an individual's global functioning (behavior as a whole), as 
well as specific elements or abilities. The use of Factor Index Scores in the WISC-IV 
emphasizes multiple factors in cognitive abilities. The increased emphasis on working 
memory recognizes its importance in learning, as well as intelligence. The Working 
Memory Index of the WISC-IV comprises the subtests Letter and Number Sequencing, as 
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well as Digit Span Forward and Digit Span Backward. Arithmetic, previously a core 
subtest, is now a supplemental one. The removal of Arithmetic as a core subtest has 
placed more emphasis on active working memory demands. The Processing Speed Index 
includes Symbol Search, as well as Coding. The WISC-IV emphasizes the processing 
demands for working memory through the renamed WMI (previously called the Freedom 
from Distractibility Index or FDD). The WMI includes the subtests, Digit Span and 
Letter-Number Sequencing. A new subtest, Cancellation, was developed for the WISC-
N to provide a supplemental processing speed subtest. The PSI did not increase 
processing demands, but Coding and Symbol Search are now core subtests, and 
Cancellation is a supplemental subtest. As a result of these changes, it is difficult to know 
whether or not WISC-III findings can be generalized to the WISC-N. 
The revision to the WISC-N represents a significant shift in composition, 
because working memory and processing speed weigh even more heavily now in the 
calculation of the Full Scale IQ Score. G. McCloskey (personal communication, April 8, 
2004), stated that where working memory and processing speed capacity were critical for 
success on two of 10 subtests (or 20% of the content) comprising the FSIQ of the WISC 
Ill, these cognitive processes have increased to 4 of the 10 subtests (or 40% of the 
content) that comprise the WISC-N Full Scale IQ Score. According to the WISC-N 
Technical and Interpretive Manual (Wechsler, 2003), processing speed and working 
memory are interrelated. Working memory, with its limited storage capacity, is reliant on 
efficient speed of processing information (Wechsler, 2003). 
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Because of the changes in content and structure of the WISC-IV and the greater 
reliance on working memory and processing speed for successful pelformance, it is very 
possible that the IQ's of ADHD children could be negatively impacted .. 
Peljormallce ofADHD Sample all WIse-IV 
As part of the initial validation of the revised edition, the WISC-IV was 
administered to 89 children aged 8-13 who were identified as having ADHD according to 
DSM-IV -TR diagnostic criteria. The ADHD group was composed of children 
representing the various ADHD subtypes (i.e., predominately inattentive, predominantly 
hyperactive-impulsive, and combined). Approximately 64% of the children in the 
ADHD group were taking medication for ADHD symptomotology at the time of testing. 
Table 5.30 and Harcourt Assessment's permission agreement are contained in Appendix 
A2 and AI, respectively. It presents the means and standard deviations of the WISC-IV 
subtest process task and composite scores for the ADHD group and a matched control 
group. The results were as follows: A moderate effect size for the group mean difference 
for the PSI was noted, and small effect sizes for the VCI, WMI, and FSIQ were also 
observed. At the subtest level, largest effect sizes for group mean scaled score 
differences occurred on the Coding and Arithmetic subtests. There were only modest 
differences on other subtests that measure working memory and processing speed. Small 
effect sizes for group mean scaled score differences occurred on Digit Span, Letter-
Number Sequencing, Symbol Search, and Cancellation. 
Inspection of this data reveals that relative to the matched control group, children 
with ADHD achieved a slightly lower mean performance on the FSIQ (97.6 vs. 102.7). 
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These differences in FSIQ are statistically significant (p value =.01), but the effect size 
(.38) is not large. These results are consistent with previous studies indicating that 
children with ADHD typically achieve scores near the normative range of intellectual 
functioning, but that their performances may be worse on measures of processing speed 
and working memory, than on measures of verbal or perceptual-organizational ability 
(Barkley, et aI., 2001; Doyle, Biederman, Seidman, Weber & Faraone, 2000). In keeping 
with previous findings of the WISC-ill, ADHD children who were administered the 
WISC-IV obtained their lowest composite score on the PSI. ADHD children scored 
lowest on the Coding subtest. Comparisons with matched controls on the WISC-IV also 
suggest that ADHD children score lower than their same-age peers on the WMI. In 
keeping with previous findings on the WISC-ill, the score obtained for the Arithmetic 
subtest was the lowest of the Working Memory tasks for the ADHD group. 
According to the WISC-IV Technical and Interpretive Manual, "additional 
research is needed with separate samples of children with ADHD based on subtype, as 
well as investigations comparing the performance of medicated and nonmedicated 
ADHD children (Wechsler, 2003, p. 89)." Although data exists, and is coded for the 
general ADHD sample, the performance of medicated children versus nonmedicated 
children has not been analyzed. 
ADHD Treatment and Effect on Cognitive Functions 
In the United States, medication is the most commonly reported form of 
intervention for children with ADHD. Approximately 80 percent of the 11 million 
prescriptions written for methylphenidate each year are written for children (Purdie, et 
aI.,2002). 
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Research suggests that psychostimulant medication may ameliorate ADHD 
cognitive deficiencies that adversely impact working memory and processing speed, 
although results are equivocal. Studies on the effect of psychostimulants on cognition 
and learning vary according to measure and methodology used. Brown and Borden 
(1989) suggested that stimulant drug improvement occurs primarily on rote or simple 
tasks, and measures emphasizing the processing of higher-order information may be less 
influenced. Barkley (1998) noted that the impact of drugs upon behavior and 
concentration was most salient, with performance on intelligence tests less affected by 
medication. Barkley (1998) also cited research that consistently showed the positive 
effects of psychostimulants on hyperactivity, on attention, on concentration, and on 
classroom behavior (DuPaul, Barkley, & McMurray, 1994; Pelham & Milich, 1991). 
However, most of these studies extrapolated IQ scores either from short forms or from 
several subtests of the Wechsler Scales. 
Livingston, et al. (1996) failed to detect significant differences on cognitive 
functioning between medicated children, nonmedicated children, and adolescents with 
ADHD. Their study compared WISC (Revised or Third Edition) scores of medicated 
children and nonmedicated children with ADHD. The results of profile analysis 
indicated that the profiles were parallel and coincident. Both groups (medicated and 
nonmedicated) were characterized by relatively poor performance on the Wechsler 
Freedom from Distractibility Index (FDD) factor (i.e., Arithmetic, Digit Span, & Coding 
subtests). Livingston, et al. put forth several hypotheses for the discrepancy between the 
positive short-term effects of psychostimulants on behavioral and cognitive functioning, 
and a lack of parallel long-term improvement on more traditional intellectual, 
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neuropsychological and achievement measures. Lack of random assignment to 
medicated/nonmedicated groups, and intergroup differences may confound group 
comparisons regarding null findings. 
Goldstein and Goldstein (1990) noted that psychostimulants enhance the 
functioning of subcortical attentional centers; however, they have limited effect on the 
informational processing abilities of the cortical areas. Because the measures included in 
their studies, and many other similar ones (Kagan, 2000; Saklofske, Schwean & 
O'Donnell, 1996; Tannock, Martinussen & Frijters, 2000), primarily assessed cortical 
functioning, they would not be expected to detect enhanced subcortical functioning. 
Finally, Livingston, et al. (1996) noted the effect of the homeostatic mechanism of down-
regulation of receptors across brain sites. Neuronal adaptations take place via the 
mechanisms of up-regulation or down-regulation. Chronic exposure to stress or to 
certain dmgs causes a bombardment by certain excitatory neurotransmitters. This often 
leads to down regulation (reduction in the number and density) of excitatory receptors 
(Preston, O'Neal & Talaga, 2002). The neural systems responsible for short-term 
cognitive gains may down-regulate after prolonged use of psychostimulants, but systems 
responsible for behavioral improvements may demonstrate limited down regulation. 
Livingston, et al. concluded that failure to document long-term improvement in 
neurocognitive abilities should not be taken as an indictment against the use of 
psychostimulant medication for attention disorders, simply that ancillary interventions are 
needed. 
Because many ADHD children receive psychopharmacological treatment, the fact 
that treated samples show neuropsychological deficits is relevant to many clinicians and 
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educators_ Doyle, et aI. (2000) noted that further study of ADHD persons before, and 
after the use of stimulant and other medications, is necessary to determine the impact of 
medications on test sensitivity. Fararone (2003) reviewed methods for comparing drugs 
across studies, and provided examples of how they can be applied to the medicines that 
treat ADHD. He used Cohen's (1988) Standardized Mean Difference (SMD) to report 
efficacy in terms of continuous measurements. Faraone calculated effect sizes for 
stimulants and nonstimulants in the treatment of ADHD, and found greater effect for 
stimulants than nonstimulants (.9 versus .6), with long acting stimulants having a slightly 
larger effect size. For example, if a medication increased IQ by 3 points, it would be 
considered a small effect, an increase of 7.5 IQ points, a medium effect, and an increase 
of 12 IQ points would be considered a large effect size. Faraone found that 
nonstimulants increased IQ by 9 points, but stimulants, both immediate release and long-
acting stimulants, increased IQ by 14 points. 
Studies that have examined the short-term effects of methylphenidate on the 
WISC-III have failed to reveal significant methylphenidate treatment effects for subtest, 
index, or VIQ and PIQ scores (Saklofske, et aI., 1993; Schwean, et aI., 1993). Prifitera, 
et aI. (2005) noted that given the results of medication on WISC-Ill performance, it 
seems unlikely that the WISC-IV findings that were based on samples of ADHD children 
which included a large percentage who were being treated with pharmacological agents, 
would have been affected by medication; although, he stated that this was an issue for 
future research to address. However, the WISC-IV standardization data was not analyzed 
by treatment. It is possible that medicated ADHD children achieved significantly higher 
scores on the WISC-IV. 
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Despite reported large effect sizes for stimulant medication on intelligence scores 
in the Faraone study, the literature on long-term results of psychostimulants on cognitive 
functioning is sparse. The results of a long-term, placebo controlled study (Gillberg, et 
a1., 1997) of amphetamine in the treatment of ADHD, found that positive effects of the 
drug remained 15 months after the start of treatment. With respect to change in WISC-R 
scores, a comparison was made between children who had been taking placebo for 6 
months or more, with those who had been taking amphetamine for 9 months or more. 
Their prediction was that the latter group would show greater increases in IQ scores. The 
mean change in IQ from 0 to 15 months was +4.5 (SD, 4.7) in the group treated with 
amphetamine for 9 months or more, and +0.7 (SD, 7.2), in the group-receiving placebo 
for 6 months or more. In the former group, 28 of 34 individuals changed in a positive 
direction as they had predicted, whereas in the latter group, only 4 of 8 did. Verbal 
scores did not increase more than performance scores did in any of the groups. 
The Multimodal Treatment Study of Children with ADHD (The MTA 
Cooperative Group, 1999) assessed specific treatment modalities in 579 children aged 7 
to 9.9 years with ADHD, Combined Type. In this 14-month randomized clinical trial, 
patients were assigned to various treatment modalities including medical management 
(i.e., pharmacotherapy), behavioral treatment, a combination of medical and behavioral 
management, or community-based treatment. 
Although it did not assess intelligence test scores, the MTA study is presently the 
largest study of medication effects on ADHD symptomotology. The results demonstrated 
that children receiving medical management, or combined treatment had significantly 
greater improvement in hyperactive-impulsive symptoms than those receiving either 
30 
behavioral treatment alone, or community-based treatment. Symptomatic improvement 
differences between those receiving only medical treatment, and those receiving 
combined treatment were not statistically significant. For other areas of function, 
including academic achievement, few differences among the treatments were noted, 
except for the reading achievement score on the Wechsler Individual Achievement Test. 
The MTA study extended the findings of previous studies that demonstrated short-term, 
robust efficacy of medication management, showing that these benefits persist during 
treatment up to 14 months. Nevertheless, essentially all recently published practice 
guidelines or consensus statements support the use of psychosocial interventions either 
alone, or in combination with pharmacotherapy (Dulcan, 1997; NIH consensus statement, 
1998; American Academy of Pediatrics Subcommittee on ADHD, 2001). The results of 
the MTA study clearly demonstrated the efficacy of medication as a treatment for ADHD 
for a sustained period. Less evident is the preferred treatment for the inattentive 
symptoms that interfere with cognitive processes. 
ADHD Treatment/Gender and Multicultural Differences 
As reviewed by Bussing, Zima, Gary and Gat'van (2003), several studies indicate 
that girls and children from minority backgrounds are significantly less likely to receive 
ADHD treatment, including psychotropic medications, than are boys and Caucasian 
children, respectively (Rowland, et al., 2002; Zarin, Suarez & Pincus, 1998). Although 
Rowland, et a1. found a similar rate of diagnosis among White and African-American 
children, medication treatment rates were higher among White children, particularly 
boys, compared with African-American or Hispanic children (8%, 5% and 2%, 
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respectively). Bussing, et al., found that boys had more than five times the probability of 
receiving an evaluation, an ADHD diagnosis, and treatment than did girls. 
A report from the U.S. Department of Health and Human Services (2002) noted 
the increase in ADHD diagnosis in children, but lower treatment rates for some groups, 
including girls, and minorities receiving care through public service systems. Many 
studies showed higher treatment rates for boys than for girls, and for whites as opposed to 
nonwhites. This disparity in treatment rates may account for the growing recognition that 
many children who do meet the criteria for ADHD are not being treated. The publication 
of DSM-N-TR (APA, 2000) text revision, has added new emphasis to the influence of 
culture on diagnosis by including an outline for cultural formulation, and a glossary of 
culture-bound syndromes. The manual recognizes that culturally diverse individuals 
have special needs, and require special skills and knowledge to receive appropriate and 
effective treatment. 
Conclusions 
The DSM-N has contributed to increased accuracy and reliability in the diagnosis 
of ADHD, and possibly in its increased prevalence, which is estimated as between 4% to 
12% of all school-aged children (APA, 2000). However, the current diagnostic approach 
to ADHD is subjective because of its dependency on accuracy of informant report, and 
on history. Barkley (1998) theorized that ADHD comprises a deficit in behavioral 
inhibition that is linked to neuropsychological abilities. He theorized that ADHD results 
in specific cognitive impairments, such as working memory and processing speed 
deficits. Wu, et al., (2002) suggested a resource allocation model, in which ADHD is 
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associated with a state regulation deficit, rather than real limitations of attention or 
executive capacities. Ruckledge and Tannock (2002), from their study differentiating 
ADHD from Reading Disabled adolescents, concluded that neuropsychological indicators 
such as verbal working memory and processing speed, rather than behavioral inhibition 
might be central to ADHD deficits. 
Gender and ethnic disparities exist in findings which concern diagnosis and 
treatment of ADHD. Yet, the majority of research on ADHD has been based almost 
exclusively on white, middle class males. Kendall and Hatton (2002) noted that 
prevalence rates of ADHD among nonwhite, American ethnic minority groups are rarely 
reported, and have not been established. These researchers posited that this is due to 
underlying racist assumptions, calling for the need by researchers to adopt a viewpoint of 
multiculturalism that acknowledges the cultural context of all health processes. Findings 
of several international cross-cultural studies (Anderson, et al., 1980; Brewis, et al., 2001) 
indicate that ADHD exists worldwide, with international prevalence rates similar to US 
rates. Treatment of ADHD is also influenced by race and gender, with more 
prescriptions written for white, middle class boys. As reviewed by Bussing, et al. (2003), 
several studies indicate that girls and children from minority backgrounds are 
significantly less likely to receive ADHD treatment than are boys, and Caucasian 
children respectively; this treatment includes psychotropic medications (Rowland, et al., 
2002; Zarin, et al., 1998). 
Recent advances in medical technology have led to refined causal explanatory 
hypotheses of ADHD. ADHD is currently characterized as a condition involving 
executive control difficulties. Some contemporary research shows that the cognitive 
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processes of working memory and processing speed are most highly affected by ADHD. 
Research also indicates that ADHD appears to affect overall level of performance on 
intelligence tests (Barkley, 2000; Mahone, et al., 2003). 
Research on the performance of ADHD children on standardized intelligence 
tests suggests that some degree of intellectual impairment is a core feature of ADHD. 
Research also suggests that the effect of ADHD on IQ can be greatly influenced by the 
nature of the cognitive tasks used to assess FSIQ. Comparisons of ADHD children and 
normative samples on the Wechsler Scales showed differences not only on FSIQ, but also 
on index and domain scores. Comparisons of ADHD children on the WISC-R and 
WISC-III showed declining scores, suggesting that as processing or executive demands 
increase on Wechsler revisions, IQ scores decrease. The latest revision, the WISC-IV, 
with its greater contribution of processing speed and working memory to FSIQ, has 
implications for cognitive performance of ADHD children. 
Psychostimulants are the major intervention for control of ADHD stymptoms. 
Studies on the effect of psychostimulants on cognition and learning vary according to the 
measure and methodology used. Livingston, et al., (1996) failed to detect significant 
differences on cognitive functioning between medicated children, nonmedicated ADHD 
children, and adolescents. Both groups were chmacterized by their relatively poor 
performance on the WISC-III FDD factor. These authors noted that intergroup 
differences and research design might confound group comparisons. They concluded that 
failure to document long-term improvement in neurocognitive abilities should not be 
taken as an indictment against the use of psychostimulant medication of ADHD, simply 
that ancillary interventions are needed. 
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Faraone (2003) reviewed methods for comparing medications across studies, and 
calculated effect sizes for stimulants and nonstimulants in the treatment of ADHD. Using 
Cohen's (1988) standardized mean difference to report efficacy in terms of continuous 
measurements, Faraone found greater effect for stimulants, than nonstimulants on 
increasing IQ scores. Nonstimulants increased IQ by 9 points, but stimulants, both 
immediate release and long acting, increased IQ by 14 points. Despite this finding, the 
literature on long-term results of psychostimulants on IQ is sparse. Gillberg, et al. (1997) 
found positive effects (increase in IQ) of the drug remained 15 months after the start of 
treatment, compared to the placebo group. 
The WISC-IV Technical Manual (Wechsler, 2003) compared cognitive 
performance of an ADHD sample to a matched control group on WISC-IV subtest, 
process task, and composite scores. Results of the comparison found a moderate effect 
size for the group mean difference for the PSI, and small effect sizes for the VCI, WMI, 
and FSIQ. At the subtest level, the largest effect sizes for group mean scaled score 
differences occurred on the Coding and Arithmetic subtests. Only modest differences 
were found on other subtests that measured working memory and processing speed. That 
is, there were only small effect sizes for the group mean scaled score differences on Digit 
Span, Letter-Number Sequencing, Symbol Search, and Cancellation. However, results 
were not analyzed separately for treatment effects. It is possible that medicated ADHD 
children outperformed nonmedicated samples in comparison to the matched control 
group. Additional research is needed to compare cognitive performance of medicated 
children with the cognitive pelformance of nonmedicated ADHD children. 
35 
Questions 
Given the literature suggesting that executive control difficulties are present in 
children with ADHD, and that these difficulties are linked to the cognitive processes of 
working memory and processing speed, to what extent do these difficulties impact on the 
cognitive performance of ADHD children? What is the effect of ADHD on scores from 
intelligence tests such as the WISe-IV, that assess working memory and processing 
speed as part of a global estimate of intellectual ability? Is there any difference in the 
cognitive performance of medicated children and nonmedicated ADHD children, 
compared to the pelformance of a control group of non-ADHD children? 
The increased working memory and processing speed task demands of the WISe-
IV have implications for interpretation of IQ test findings of ADHD children. There is a 
paucity of research on the effects of ADHD (with or without medication), on cognitive 
abilities as measured by a full-scale intelligence test. The current study will assess the 
impact of ADHD on WISe-IV IQ scores, and explore the relationship of medication use 
and test scores. The advantage of this study is the comparison of four groups, ADHD 
medicated and ADHD nonmedicated children and their matched control groups on the 
recent revision of one of the most respected and frequently used, full-scale tests of 
intelligence, the WISe-IV. Prifitera, et a1. (2005) indicated that the WISe-IV can 
effectively measure the clinical features and cognitive characteristics of ADHD. It also 
has considerable clinical value for monitoring cognitive changes of paramount 
importance in determining the efficacy of medical, psychological, and educational 
programs. An added advantage of the WISe-IV is that it is part of a larger family of 
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linked and co-normed tests that are also relevant to diagnosing and assessing children 
with ADHD. 
The present study will extend the work done by the standardization of the WISe-
lY sample, and explore the differences in cognitive performance between medicated and 
nonmedicated ADHD children on the WISe-IV. Results will be compared with the 
ADHD standardization sample of the WISe-IV to see if medication significantly 
improves pelformance on process/composite scores. Analysis of domain and process 
scores will assist in obtaining increased understanding of how ADHD affects the 
cognitive processes of working memory and processing speed, and whether or not 
medication has a significant effect on WISe-IV scores. These results will help to 
elucidate how cognitive deficits associated with ADHD can interfere with measurement 
of skills linked to everyday learning activities. Identifying cognitive strengths and 
weaknesses may lead to more specific educational planning. Also, consumers may be 
better able to make informed decisions about the efficacy of medication as an 
intervention for ADHD. 
Definition of Terms 
Working memory is the ability to attend to and hold information in short-term 
memory, while performing some operation or manipulation with it (Wechsler, 2003). For 
the purpose of this study, working memory will be measured either by the Working 
Memory Index (WMI) standard score of the WISe-IV, or by the subtest scaled scores on 
Digit Span and Letter-Number Sequencing. The WMI subtests measure attention, 
concentration, and working memory. 
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Processing speed is an indication of the rapidity with which one can mentally 
process simple or routine information without making errors (Wechsler, 2003). For the 
purpose of this study, either the Processing Speed Index (PSI) standard score of the 
WISC-IV, or the subtest scaled scores of Coding or Symbol Search will measure 
processing speed. The PSI subtests measure the speed of mental and graphomotor 
processmg. 
Verbal reasoning is the ability to reason with orally presented verbal information. 
The Verbal Comprehension subtests of the WISC-IV are designed to measure verbal 
reasoning and concept formation (Wechsler, 2003). For the purpose of this study, verbal 
comprehension will be measured either as the Verbal Comprehension Index (VCI) 
standard score of the WISC-IV, or as the subtest scaled scores of Vocabulary, 
Similarities, and Comprehension. The VCI is composed of subtests measuring verbal 
abilities utilizing reasoning, comprehension, and conceptualization. 
Perceptual Reasoning is the ability to reason with visually presented nonverbal 
material. The Perceptual Reasoning Index is designed to measure concept formation with 
nonverbal stimuli (Wechsler, 2003). For the purpose of this study, perceptual reasoning 
will be measured either by the Perceptual Reasoning Index (PRI) standard score of the 
WISC-IV, or by the subtest scaled scores of Block Design, Picture Concepts, and Matrix 
Reasoning. 
Early intelligence tests emphasized the classification of individuals based on their 
overall level of cognitive functioning (Wechsler, 2003). General intellectual functioning 
is usually expressed as a summary or composite score, such as the Full Scale IQ (FSIQ). 
Sattler (2001) noted that the FSIQ is a global estimate of the child's level of cognitive 
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ability; it assesses both crystallized and fluid intelligence. For the purpose of this study, 
general intellectual functioning will be defined as the FSIQ composite score of the 
WISC-N. 
The ADHD sample will be operationally defined as male students between the 
ages of 8 and 13 who have been diagnosed with this disorder by a physician or clinical 
psychologist and this information has been indicated by a note in their record files. 
Medication will be defined as medication used to control for the symptomotology of 
ADHD. 
Research Hypotheses 
Given the literature suggesting that executive control difficulties are present in 
children with ADHD, and that these difficulties are linked to working memory and 
processing speed which result in lower IQ scores, the following hypotheses will be 
studied: 
1. 	 It is predicted that ADHD diagnosis has no effect on group mean 
FSIQ scores on the WISC-IV. FSIQ scores of an ADHD sample will be 
comparable to the FSIQ scores of a matched control nonADHD sample. 
2. 	 It is predicted that ADHD diagnosis has no effect on group mean index scores 
on the WISC-N as follows: 
a. 	 Processing Speed Index (PSI) scores of an ADHD sample will 
be comparable to the PSI scores of a nonADHD matched 
control sample. 
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b. 	 Working Memory Index (WM) scores of an ADHD sample 
will be comparable to the WMI scores of a nonADHD matched 
control sample. 
c. 	 Perceptual Reasoning Index (PRI) scores of an ADHD sample 
will be comparable to the PRI scores of a nonADHD matched 
control sample. 
d. 	 Verbal Comprehension Index (VCI) scores of an ADHD 
sample will be comparable to the VCI scores of a nonADHD 
matched control sample. 
3. 	 It is predicted that ADHD diagnosis has no effect on group mean subtest 
scores on the WISC-IV as follows: 
a. 	 Coding (CD) subtest scores of an ADHD sample will be 
comparable to the CD sub test scores of a nonADHD matched 
control sample. 
b. 	 Symbol Search (SS) scores of an ADHD sample will be 
comparable to the SS subtest scores of a nonADHD matched· 
control sample. 
c. 	 Letter-Number Sequencing (LN) subtest scores of an ADHD 
sample will be comparable to the LN subtest scores of a 
nonADHD matched control sample. 
d. 	 Digit Span (DS) subtest scores of an ADHD sample will be 
comparable to the DS subtest scores of a nonADHD matched 
control sample. 
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e. 	 Matrix Reasoning (MR) subtest scores of an ADHD sample 
will be comparable to the MR subtest scores of a nonADHD 
matched control sample. 
f. 	 Picture Concepts (PCn) subtest scores of an ADHD sample 
will be comparable to the PCn subtest scores of a nonADHD 
matched control sample. 
g. 	 Block Design (BD) subtest scores of an ADHD sample will be 
comparable to the BD subtest scores of a nonADHD matched 
control sample 
h. 	 Similarities (SI) subtest scores of an ADHD sample will be 
comparable to the SI subtest scores of a nonADHD matched 
control sample. 
i. 	 Comprehension (CO) subtest scores of an ADHD sample will 
be comparable to the CO subtest scores of a nonADHD 
matched control sample. 
J. 	 Vocabulary (VC) subtest scores of an ADHD sample will be 
comparable to the results of a nonADHD matched control 
sample. 
Given the lack of clarity in the literature on the effect of medication on ADHD 
children's 1Q scores, the following hypotheses will be studied: 
4. 	 It is predicted that ADHD treatment status has no effect on group mean FS1Q 
scores. FS1Q scores of an ADHD nonmedicated sample, and an ADHD 
medicated sample will be comparable to the FS1Q scores of their nonADHD 
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matched controls. 
5. 	 It is predicted that ADHD treatment status has no effect on group mean index 
scores on the WISC-IV as follows: 
a. 	 Processing Speed Index (PSI) scores of an ADHD 
non medicated ADHD sample, and an ADHD medicated 
sample will be comparable to the PSI scores of their nonADHD 
matched control sample. 
b. 	 Working Memory Index (WMI) scores of an ADHD 
nonmedicated ADHD sample, and an ADHD medicated 
sample will be comparable to the WMI scores of their 
nonADHD matched control sample. 
c. 	 Perceptual Reasoning Index (PRI) scores of a nonmedicated 
ADHD sample, and an ADHD medicated sample will be 
comparable to the PRI scores of their nonADHD matched 
control sample. 
d. 	 Verbal Comprehension Index (VCI) scores of a nonmedicated 
ADHD sample, and an ADHD medicated sample will be 
comparable to the VCI scores of their nonADHD matched 
control sample. 
6. 	 It is predicted that ADHD treatment status has no effect on group mean 
subtest scores on the WISC-IV as follows: 
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a. 	 Coding (CD) subtest scores of a nonmedicated ADHD sample, and an 
ADHD medicated sample will be comparable to the CD subtest scores 
of their nonADHD matched control sample. 
b. 	 Symbol Search (SS) subtest scores of a nonmedicated ADHD sample, 
and an ADHD medicated sample will be comparable to the SS subtest 
scores of their nonADHD matched control sample. 
c. 	 Letter-Number Sequencing (LN) subtest scores of a nonmedicated 
ADHD sample, and an ADHD medicated sample will be comparable 
to the LN subtest scores of their nonADHD matched control sample. 
d. 	 Digit Span (DS) subtest scores of a nonmedica(ed ADHD sample, and 
an ADHD medicated sample will be comparable to the DS subtest 
scores of their nonADHD matched control sample. 
e. 	 Matrix Reasoning (MR) subtest scores of a nonmedicated ADHD 
sample, and an ADHD medicated sample will be comparable to the 
MR subtest scores of their nonADHD matched control sample. 
f. 	 Picture Concepts (PCn) subtest scores of a nonmedicated ADHD 
sample, and an ADHD medicated sample will be comparable to the 
PCn subtest scores of their nonADHD matched control sample. 
g. 	 Block Design (BD) subtest scores of a nonmedicated ADHD sample, 
and an ADHD medicated sample will be comparable to the BD subtest 
scores of their nonADHD matched control sample. 
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h. 	 Similarities (SI) subtest scores of a nonmedicated ADHD sample, and 
an ADHD medicated sample will be comparable to the SI subtest 
scores of their nonADHD matched control sample. 
J. 	 Comprehension (CO) subtest scores of a nonmedicated ADHD 
sample, and an ADHD medicated sample will be comparable to the 
CO subtest scores of their nonADHD matched control sample. 
j. Vocabulary (VC) subtest scores of a nonmedicated ADHD sample, and 
an ADHD medicated sample will be comparable to the VC subtest 





Data archived in public school files or in the data files of The Psychological 
Corporation was accessed to obtain the test score data of 109 male students between the 
ages of 8-13, who had been diagnosed with ADHD by a physician or psychologist, and 
had been tested on the WISC-IV as part of a school district's educational referral process. 
Dates of testing ranged from January 2004 to June 2005 for the nonmedicated ADHD 
sample, and January 2003 to July 2005 for the medicated ADHD sample. Archived 
public school data was obtained from a northeastern region tri-state area (New Jersey, 
Pennsylvania, Delaware, and Maryland). Data on students identified as having other 
disabling conditions, such as a specific learning disability were not systematically 
excluded from the study. 
The ADHD data set was divided into two groups. The first group consisted of test 
data from 55 ADHD male students who were not being medicated for ADHD 
(nonmedicated). Assignment to this group required: (1) Diagnosis of ADHD, (2) a 
WISC-IV Verbal Comprehension Index (VCI) Standard Score greater than 80, (3) 
Indication that medication prescribed for the symptoms of ADHD was not being taken at 
the time of WISC-IV testing. 
The second group consisted of 54 ADHD male students who were medicated for 
this disorder. Assignment to this group required: (1) Diagnosis of ADHD, (2) a WISC-
IV Verbal Comprehension Index (VCI) Standard Score greater than 80, (3) Indication 
that medication prescribed for the symptoms of ADHD was being taken prior to, or at the 
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time of WISC-N testing. Information on whether or not medication was taken was 
based either on parent report, or on information from the student's file. 
In addition to the ADHD groups, data was collected for a nonADHD sample. This 
nonADHD sample was based on archived data obtained from The Psychological 
Corporation of the WISC-N standardization sample of 109 male students between the 
ages of 8-15 who were reported as residing in the northeast or north central regions. This 
nonADHD sample consisted of two groups. One group, 55 males were matched to the 
ADHD nonmedicated group of 55 males. The other group of 54 males was matched to 
the examiner's ADHD medicated group of 54 males. The nonADHD control group was 
matched on the basis of chronological age, gender, ethnicity, parent education level, 
geographic region, and Verbal Comprehension Index. 
Ethical considerations assured confidentiality by removing identifying 
information such as name and date of birth. Only archived data was collected. 
Information collected on data collection forms were secured in a locked file cabinet. Test 
scores and protocols collected by the examiner were protected from unauthorized release 
and access. Test scores were interpreted in conjunction with other information obtained 
about the test taker. The researcher was mindful of practice parameters for the use of 
medication in the treatment of children and adolescents. Withholding of treatment was 
not prescribed, as the nonmedicated group was predetermined by parental choice. When 
analyzing data, consideration was made of such variables as context and culture, as well 
as the limitations of current research and practice. The research avoided using 
stigmatizing labels. Ecological factors, such as risk and protective factors were 




The primary independent variables in this study were: ADHD diagnostic status 
(either ADHD or nonADHD), and treatment status (ADHD medicated or ADHD 
nonmedicated) . 
Dependent Variables 
Dependent variables investigated in the study included WISC-IV FSIQ and PSI, 
WMI, PRI, and VCI Index Standard Scores, and all 10 core subtest scaled scores (CD, 
SS, LNS, DS, MR, PCn, BD, SI, CO, VC). 
Overview of the Research Design 
Participants were assigned to groups based on diagnosis and treatment status. 
Mean standard scores on the WISC-IV were compared between an ADHD sample, and a 
nonADHD matched control sample. Mean standard scores on the WISC-IV were 
compared among an ADHD nonmedicated sample, an ADHD medicated sample, and 
their nonADHD matched control samples. 
Measure and Procedures 
A letter requesting permission to collect data was sent to superintendents of 
selected schools. Once permission was obtained by return of the signed permission form, 
School Psychologists at the selected schools were asked to record WISC-IV test scores 
and demographic information from a student's record file on a data collection form. No 
identifying information was collected. Data used in this study had already been 
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collected. The data collection form requested raw and standard scores of the 10 core 
subtests, as well as index scores. The demographic information listed information such as 
chronological age, gender, ethnicity, and parent education level. Diagnosis status, 
treatment status, brand name of medication, dosage and time medication was taken were 
also recorded. Interval data (subtest and composite scores) from the WISC-IV was 
collected. Raw and scaled scores were recorded. Obtaining raw scores allowed for a 
check of the accuracy of the standard scores. 
The use of WISC-IV test scores allowed for comparisons of multiple analyses 
(subtest, domain and full scale scores) of ADHD samples, medicated and nonmedicated, 
and the nonADHD samples. The WISC-IV is a valid and reliable instrument with 
sufficient test sensitivity to measure the processing demands of working memory and 
processing speed. More than 60 years of research support the practical and clinical utility 
of the Wechsler scales across a wide range of settings and purposes (Sattler, 2001). 
These scales have demonstrated clinical utility for purposes as identification of mental 
retardation and learning disabilities, placement in specialized programs, clinical 
intervention, and neuropsychological evaluation (Beres, Kaufman, & Perlman, 2000). 
Further support of a theoretical basis in the Wechsler scales is evident in the appearance 
of the same or similar sub tests in other measures of intelligence, and the high correlation 
of Wechsler intelligence scales with other measures of cognitive ability (Wechsler, 
2003). 
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Chapter 3  
Results  
Results of statistical tests described in Chapter 2 are presented in this chapter. The 
aspects of the study that are described include the final composition of the sample, the 
statistical analyses used to test the hypotheses, and the results of the data analyses. Data 
was initially entered into an excel spreadsheet and then exported to an SPSS file. Data 
was analyzed using the Statistical Package for the Social Sciences (SPSS-13.0). The 
level of significance criteria for testing hypotheses was set at .05, although the use of the 
SPSS data analysis package allows for reporting of specific significance levels for each 
hypothesis test. 
Demographic Information 
The ADHD sample for this study comprised 109 male students between the ages 
of 8-13 who had been diagnosed with ADHD, and tested on the WISC-N as part of a 
school district educational referral process. The ADHD sample was further divided into 
two groups. The first group consisted of 55 ADHD male students who were not being 
medicated for their diagnosed ADHD condition. The second group consisted of 54 
ADHD male students who were being medicated as part of treatment for the disorder. 
The brand name of the ADHD medication were as follows: 19 students were taking 
Concerta (35%), 11 students were on Ritalin (5 immediate release, 6 long acting for a 
total of 20%), 10 students were taking Adderral (18%), 9 students were on Strattera 
(16%), one was on Wellbutrin (2%), one on Medidate (2%), but four of the students' 
medication type were not recorded (4% unknown). Thirty-nine of the data forms (71 %) 
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indicated that the medications were long acting; five (9%) of the forms indicated 
immediate release, and 11 (20%) were not reported. Twenty-five students took their 
medications in the morning (45%), one in the afternoon (2%), and two both a.m. and p.m. 
(4%). However, medication time was not recorded on twenty-seven data forms (49%). 
Two nonADHD samples were then selected from the archived WISC-N 
standardization data set obtained form the Psychological Corporation to serve as matched 
controls. The nonADHD sample consisted of 109 male students between the ages of 8-15 
who were reported as residing in the northeast or north central regions of the tri-state 
area. The nonADHD sample was further divided into two control groups. One group of 
55 males was matched to the ADHD nonmedicated group (Control 1). A second group of 
54 nonADHD males was matched to the ADHD medicated group (Control 2). The 
nonADHD control group subjects were matched to the ADHD group subjects on the 
basis of chronological age, gender, ethnicity, parent education level, and Verbal 
Comprehension Index Standard Score. Appendix B provides a listing of demographic 
characteristics of the ADHD samples and their nonADHD matched controls. 
Controls were matched to their ADHD counterparts as closely as possible on 
chronological age. A majority of the subjects were identical chronological age matches. 
Some matches varied by one year, and a few cases varied by two years. The frequency 
distributions for age for the four groups, ADHD Nonmedicated, Matched Control 1, 
ADHD Medicated, and Matched Control 2 are provided in Table 1. 
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Table 1 
Frequency Distribution for Age 
Age 
Group 8 9 10 ] 1 12 13 14 ]5 
ADHD Nonmedicated 
n 17.00 7.00 6.00 8.00 6.00 11.00 
% 30.90 12.70 10.90 14.50 10.90 20.00 
Control 1 a 
n 14.00 10.00 8.00 6.00 8.00 6.00 2.00 1.00 
% 25.50 18.20 14.50 10.90 14.50 10.90 3.60 1.80 
ADHD Medicated 
n 7.00 10.00 14.00 5.00 9.00 9.00 
% 13.00 18.50 25.90 9.30 16.70 16.70 
Control2b 
n 6.00 11.00 13.00 5.00 ]0.00 8.00 1.00 
% 11.10 20.40 24.10 9.30 18.50 14.80 1.90 
Note. Age range from 8 to 15 years. 
aControl 1= nonADHD group matched to ADHD nonmedicated group 
bControl 2= nonADHD group matched to ADHD medicated group 
The largest proportion of the nonmedicated children were age 8, and the most 
frequent age for the medicated children was age 10. These frequencies are consistent 
with the literature (NSCH, 2003) that found medication by age patterns were curvilinear, 
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with prevalence of medication highest among children aged 9- 1 3 years, when compared 
to younger and older children. 
Parent Education level, which ranged from no high school diploma to graduate 
and professional school training was matched identically for the majority of the sample. 
The frequency distribution for Parent Education Level for the four groups is given in 
Table 2. 
Table 2 
Frequency Distribution for PE 
Parent Years of Education 
Diagnostic Group 9 - 11 12 13 - 15 16 or more 
ADHD Nonmedicated 
% 12.70 63.60 10.90 12.70 
Control 1 
% 7.30 58.20 16.40 18.20 
ADHD Medicated 
% 11.10 55.60 9.30 24.10 
Control 2 
% 7.40 59.30 13.00 20.40 
Note. 9-11= some high school, 12 years= high school or equivalent, 13-15 years=  
some college or associate degree, 16 or more years= college or graduate degree,  
Matched control 1= ADHD nonmedicated control, Matched control 2=  
ADHD medicated control.  
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Parents of both medicated children and non medicated ADHD children most 
frequently reported having twelve years of education. Twice as many parents of 
medicated ADHD children had 16 or more years of education, when compared to the 
parents of nonmedicated children. The parent education distributions reported for the 
medicated and nonmedicated ADHD groups are very similar to those reported in the 
literature (NSCH, 2003). 
The ADHD groups were also matched to controls on the basis of ethnicity. The 
frequency distributions for ethnicity for each of the four groups are given in Table 3. 
Table 3 
Frequency Distribution for Ethnicity 
Ethnicity 
Group White Black Hispanic 
ADHD Nonmedicated 
% 78.20 18.20 3.60 
Control 1 
% 78.20 18.20 3.60 
ADHD Medicated 
% 83.30 14.80 l.90 
Control 2 
% 85.20 13.00 l.90 
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FinaUy, the ADHD groups were matched to controls by Verbal Comprehension 
Index scores. The characteristics of the ADHD sample and their nonADHD matched 
controls are listed in Appendix B. VCl scores of the ADHD groups ranged from a low of 
80 to a high of 142. ADHD children with VCl scores below 80 were not included in the 
study. 
VCl means and standard deviations of the four groups are included in table 4. 
Table 4 
Verbal Comprehension/ndex Scores by Group 
Group M SD 
ADHD Nonmedicated 101.16 13.07 
Control 1 100.93 12.93 
ADHD Medicated 101.20 13.69 
Control 2 101.31 14.00 
Statistical Analysis 
Control groups were matched to the ADHD groups on demographic factors of 
age, parent education level, ethnicity, and the Verbal Comprehension Index to the degree 
that no significant differences were found in the proportions of controls compared to their 
ADHD counterparts. Prior to the testing of the study hypotheses, the assumption of 
homogeneity of group variances was tested for aU study variables using the Levene 
statistic to determine the extent to which the data met the assumptions required for 
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appJopriate use of parametric inferential statistical tests of significance. No significant 
differences were found among the variable variances of the ADHD groups and their 
matched control counterparts, indicating that the use of parametric inferential statistical 
procedures was appropriate for all variables used in the study. 
Hypotheses Tests 
Tests of the hypotheses involving the ADHD and nonADHD samples and their 
matched controls utilized three separate analyses: 
1) A one-way ANOVA was conducted to test the null hypothesis of no difference 
between the mean FSIQ of the nonmedicated and medicated ADHD, and the nonADHD 
samples and their matched controls; 
2) A MANOVA was conducted to test the hypotheses of no difference between 
mean PSI Standard Scores of the ADHD and nonADHD samples, and their matched 
controls, no difference between mean WMI Standard Scores of the ADHD and 
nonADHD samples, and their matched controls, no difference between mean PRI 
Standard Scores. of the ADHD and nonADHD samples and their matched controls, and 
no difference between the VCI Standard Scores of the ADHD and nonADHD samples 
and their matched controls; and, 
3) A MAN OVA was conducted to test the hypotheses of no difference between 
mean subtest scaled scores for the ADHD and nonADHD samples and their matched 
controls for each of the 10 WISC-IV core subtests (CD, SS, LNS, DS, MR, PCn, BD, SI, 
CO, VC). 
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Follow-up tests of significant differences were conducted using Fisher's Least 
Significant Difference (LSD) statistic. 
Results ofHypotheses Tests 
The FSIQ, Index, and Subtest means and standard deviations of the four groups 
are listed in Tables 5 and 6. 
Table 5 
Index Mean Score by Group 
Diagnostic Group 
ADHD nonMed Control 1 ADHDMed Conto12 
Index 
Scores 
(N=54) (N=54) (N=55) (N=55) 
M SD M SD M SD M SD 
VCI 101.16 13.07 100.93 12.93 101.20 13.69 101.31 14.00  
PRI 97.73 13.72 100.20 14.37 103.31 12.47 101.61 14.23  
WMI 92.42 1(39 99.11 12.43 95.61 14.13 99.35 12.39  
PSI 91.65 11.57 97.16 13.96 94.43 13.99 94.89 14.58  
FSIQ 95.64 11.61 99.64 13.79 98.96 12.49 99.57 13.42  
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Table 6 
Subtest Scores by Group 
Diagnostic Group 
ADHDNonmed Control 1 ADHDMed Contol2 
Subtest 
Scores (N=54) (N=54) (N=55) (N=55) 
M SD M SD M SD M SD 
SI 10.27 2.72 10.51 2.70 10.61 2.73 10.15 2.98 
VC 10.13 2.86 10.31 2.74 10.02 2.73 10.44 2.64 
CO 10.33 2.51 9.80 2.48 10.19 2.84 10.20 2.67 
BD 9.64 3.26 10.20 2.92 10.17 2.95 10.15 2.81 
PCN 10.05 2.83 9.93 2.77 10.91 2.22 10.31 2.49 
MR 9.40 2.69 9.89 2.89 10.44 2.79 10.28 3.08 
DS 8.64 2.30 10.16 2.63 9.59 2.99 9.98 2.31 
DSF 9.00 2.88 10.36 2.50 9.37 2.71 10.15 2.86 
DSB 8.83 2.29 9.95 2.62 9.80 3.15 9.93 2.53 
LNS 8.89 3.17 . 9.78 2.92 9.11 3.08 9.98 3.16 
CD 7.98 2.32 9.40 2.95 8.74 3.17 8.96 2.97 
SS 8.93 2.25 9.55 2.82 9.26 2.61 9.20 3.23 
Tests ofHypotheses 1 and 4 
The omnibus F test applied to the means of the 4 groups (F (3,214) = 1.20, p < .311) 
indicated there were no statistically significant differences between the mean FSIQ scores 
of any of the groups. The results of the test of Hypotheses 1 and 4 using the univariate 
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analysis of variance (ANOVA) for group differences on the dependent variable FSIQ are 
given in Table 7. 
Table 7 
Analysis o/Variance/or FSIQ 
SS d/ MS F Sig. 
595.255 3 198.418 1.200 0.311 0.017  
Tests 0/Hypotheses 2, 3, 5 and 6 
Hypotheses 2, 3, 5, and 6 were analyzed with a multivariate analysis of variance 
(MANOVA), to test multiple dependent variables (index or subtest scores) 
simultaneously to control for Type 1 error rate inflation that could result from conducting 
multiple tests of significance among the dependent variables. Significant differences 
found during the multivariate analysis were followed up using Fisher's Least Significant 
Difference (LSD) test, with the significance level set a p < .05. 
Results of the multivariate analysis tests (MANOVA) of Hypotheses 2 and 5 for 




Multivariate Analysis for Index Scores 
Index 2SS dj MS F Sig. 17Scores 
VCI 4.361 3 1.454 0.008 0.999 0.000 
PRI 913.828 3 304.609 1.617 0.186 0.022 
WMI 1769.758 3 589.919 3.703 0.013 0.049 
PSI 843.775 3 281.258 1.527 0.208 0.021 
The F test of the group mean differences for WMI was significant (F (3,214) = 
3.70, P < .013). Although statistical differences were found for WMI group mean 
differences, the effect size is extremely small (.049). No statistically significant 
differences were found among the ADHD, nonADHD, and control groups for VCI, PRI, 
or PSI. 
The follow-up multiple comparisons of WMI mean scores among the four groups 
are shown in Table 9. 
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Table 9 
WMI Mean Difference Comparisons 
Group MD(f SE Sig.
Comparison 
ADHD med vs. ADHD nonmed 3.l9 2.418 .188 
ADHD nonmed vs. Control 1 -6.99 2.407 .006 
ADHD med vs. Control 2 -3.74 2.429 .125 
Follow-up tests of significance, conducted to test pair-wise comparisons among 
group means on the WMI revealed a statistically significant difference between the 
nonmedicated ADHD group and its matched control (p < .006). Pair-wise comparisons 
among the groups did not indicate a statistically significant difference on WMI between 
the medicated and nonmedicated ADHD groups or between the medicated ADHD group 
and its matched control. 
Tests of Hypotheses 3 and 6 involved the multivariate analysis of subtest mean 




Multivariate Analysis Results for Subtest Scores 
Subtest 
SS df MS F Sig. 112 
Scores 
SI 7.562 3 2.521 .323 .809 .005 
VC 5.367 3 1.789 .237 .871 .003 
CO 9.311 3 3.104 .452 .716 .006 
BD 12.817 5 4.272 .476 .699 .007 
PCn 34.195 3 11.398 1.693 .170 .023 
MR 39.340 3 13.113 1.605 .189 .022 
DS 76.492 3 25.497 3.842 .010 .051 
DSF 64.832 3 21.611 2.858 .038 .039 
DSB 45.649 3 15.216 2.149 .095 .030 
LNS 44.500 3 14.833 1.554 .202 .021 
CD 57.992 3 19.331 2.332 .075 .032 
SS 10.561 3 3.520 0.465 .707 .007 
The F test of the group mean differences for DS was significant (F (3, 214) = 
3.84, P < .010), but effect size (.051) was extremely small. No statistically significant 
differences were found among the ADHD, nonADHD, or control groups for any of the 
other subtests. 
Tables 11 and 12 show DSF and DSB mean and standard deviation by group. 
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Table 11 
DSF Subtest Mean and Standard Deviation by Group 
Group M SD 
ADHD Nonmedicated 9.02 2.90 
Control 1 10.36 2.50 
ADHD Medicated 9.37 2.71 
Control 2 10.15 2.86 
Table 12 
DSB Subtest Mean and Standard Deviation by Group 
Group M SD 
ADHD Nonmedicated 8.83 2.29 
Control 1 9.95 2.62 
ADHD Medicated 9.80 3.15 
Control 2 9.93 2.53 
Table 13 shows the follow-up multiple comparisons of DS mean scores among 
the four groups. 
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Table 13 
DS Mean D(fference Comparisons 
Group 
Comparison 
M D(t: SE Sig. 
ADHD med vs. ADHD nonmed 1.010 0.496 0.044 
ADHD nonmed vs. Control 1 -1.530 0.491 0.002 
ADHD med vs. Control 2 -0.340 0.498 0.496 
Follow-up tests of significance conducted to test pair wise compmisons among 
the groups on DS revealed a statistically significant difference between the nonmedicated 
ADHD and medicated ADHD group means (p < .044), and a statistically significant 
difference between the nonmedicated ADHD group and its matched control group (p < 
.002). There was not a statistically significant difference between the DS mean scores of 
the medicated ADHD group and its matched control group. 
To further examine the difference in Digit Span performance among the groups, a 
multivariate analysis was conducted using the separate Digit Span Forward (DSF) and the 




Multivariate Analysis Resultsfor Digit Span Subtest Subscores 
Dependent 
Variable 
SS df MS F Sig. 
DSF 64.832 3 21.611 2.858 .038 
DSB 45.649 3 15.216 2.149 .095 
Note. DSF =digit span forward, DSB =digit span backward 
A significant difference was found for DSF (F (3,214) =2.858, P < .038), but not 
for DSB. Table 15 shows the follow-up multiple comparisons on DSF among the four 
groups. 
Table 15 
DSF Mean Difference Comparisons 
Group 
Comparison 
M Dif. SE Sig. 
ADHD med vs. ADHD nonmed 0.354 0.539 0.513 
ADHD nonmed vs. Control 1 -1.345 0.529 0.012 
ADHD med vs. Control 2 -0.776 0.537 0.150 
Follow-up tests of significance, conducted to test pair wise comparisons among the 
groups on DSF revealed a statistically significant difference between the nonmedicated 
ADHD group and its matched control (p <.012). No statistically significant differences 
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were found between the medicated and nonmedicated ADHD groups or between the 
medicated group and its matched control group. 
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Chapter 4  
Discussion  
Summary ofResults 
This chapter includes a discussion of the results, with an emphasis toward 
understanding and interpreting the data presented and the questions tested. This study 
examined the effects of ADHD and medication use on the cognitive processes of 
children. Finally, the contributions to the field of psychology, limitations of the study, 
and recommendations for future research are discussed. 
This study did not find any statistically significant difference between the mean 
FSIQs of an ADHD medicated group, and an ADHD nonmedicated group, nor did it find 
significant differences between the mean FSIQs of the two ADHD groups, and matched 
control samples. This study did find the group mean Working Memory Index score of the 
nonmedicated ADHD group to be significantly lower than the group mean Working 
Memory Index score of the matched control group. At the subtest level, the group mean 
Digit Span subtest score of the nonnmedicated ADHD group was significantly lower than 
the Digit Span group means score for the medicated ADHD group, and the matched 
control group. At the task level, the Digit Span Forward group mean score for the 
nonmedicated ADHD group was lower than the group mean score of the matched control 
group. Although ADHD diagnosis appears to have had an effect on WMI performance 
for the nonmedicated group, this lower group mean performance did not carryover to 
reflect a significant reduction in FSIQ. 
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Significance of the Results 
Based on the literature, it was anticipated that the ADHD samples would have 
significantly lower scores on FSIQ than the non ADHD samples. The revision from the 
WISe-III to the WISe-IV represented a significant shift in composition of index and 
subtest scores. Now, working memory and processing speed subtests, thought to be the 
most vulnerable to the effects of ADHD, weigh even more heavily in the calculation of 
the FSIQ of the WISe-IV. The FSIQ findings of the present study were not consistent 
with previous research (Barkley, 1990; Barkley, DuPaul & McMurray, 1992; Faraone, et 
al., 1993; Tripp, Ryan & Peace, 2002; Zhuang, Liu & Zhang, 2001; Zimmerman & Woo-
Sam, 1997), finding lower FSIQ for ADHD samples, because no significant difference 
was observed between either of the ADHD groups and their matched controls. 
One reason for this study's lack of consistent findings with previous research that 
suggests lower FSIQ for ADHD samples may be due to methodological differences. 
Unlike this study that matched ADHD with nonADHD on ability level through the Vel, 
matching on other studies was frequently done only on the basis of demographic 
characteristics. It is very possible that different results would have been obtained if 
ability levels were allowed to vary in an uncontrolled manner between the ADHD and 
control groups. Under this more rigorous condition of matching subjects by Vel, results 
did not find that the addition of PRI, WMI and PSI tasks resulted in decreases in the 
FSIQ of ADHD children. 
The findings of this study also were not consistent with previous studies which 
suggested that the use of medication could have a significant effect on FSIQ scores of 
ADHD children (Faraone, 2003; Gillberg, et al., 1997), because no significant differences 
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were found between group mean FSIQs of the nonmedicated and medicated groups. The 
inconsistency of the present findings with those of previous studies could be due partly to 
differences in methodology, such as lack of random assignment to 
medicated/nonmedicated groups, as well as intergroup differences that may confound 
group comparisons. Faraone (2003) reviewed methods for comparing drugs across 
studies and provided examples of how they can be applied to the medicines that treat 
ADHD. He used Cohen's (1988) Standardized Mean Differences to report efficacy in 
terms of continuous measurements in order to calculate the effect size of medication use. 
Limited power, as well as extremely small effect sizes of significant group 
differences (shown in Tables 7 and 9) may also contribute to the lack of consistency with 
previous findings. There are few studies on the long-term effects of stimulant 
medication. Gillberg et a1. used a long-term, placebo-controlled study that found 
improved results on the WISC-R with medicated ADHD children. However, the sample 
size was small, and type II errors could not be excluded as a possible source of the 
differences. 
At the Index level, this study found significant differences among the groups only 
on the WMI, specifically on DS, in which there was a significant difference between 
medicated children and nonmedicated ADHD children, and nonmedicated ADHD 
children, and their matched control group. Based on the results of the WISC-IV clinical 
study reported in the standardization manual (Wechsler, 2003), in which there was a 
moderate effects size for group mean differences on the PSI, similar differences were 
expected on the PSI in this study, particularly since the PSI now includes the subtests 
Symbol Search, as well as Coding. 
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In the standardization study of the WISC-IV (Wechsler, 2003), at the subtest 
level, one of the largest effect sizes for group mean scaled score differences occurred on 
Coding. Working Memory, as well as Processing Speed, is also dependent on initial 
registration of information. The literature (Weiler, Berstein, Bellinger & Waber, 2002; 
Ruckledge and Tannock, 2002) suggest that ADHD is associated with problems in verbal 
working memory, and slower verbal retrieval speed. Martinussen, Hayden, Hogg-
Johnson and Tannock (2005), in their meta-analysis of working memory in ADHD 
children 4-18 years of age, examined separate domains of working memory: verbal and 
spatial storage, and verbal and spatial central executive function. Their meta-analyses 
indicated moderate-to-Iarge working memory impairment associated with ADHD in all 
domains, spatial more than verbal. Limitations included lack of addressing medication 
status, small number of studies, especially in the spatial domain, and publication bias. 
In light of previous research (Krane & Tannock, 2001; Mayes, Calhoun & 
Crowell, 1999) that found significantly lower mean subtest scores for ADHD groups on 
Digit Span, Arithmetic, Coding and Symbol Search, greater differences were expected 
between the ADHD and non ADHD groups on subtests, as well as index scores. These 
expectations existed particularly in light of the greater involvement of attention, working 
memory, and executive function processes in completion of the tasks on these subtests. 
This study found significant differences among the groups at the subtest level only on 
Digit Span. It is conceivable that differences would have been found in performance 
among the groups on subtests such as MR and PCn because of the executive functions 
involved in the tasks. For example, despite good reasoning and organization ability, 
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impulsive responding and poor attention to detail, as well as spatial working memory 
problems may result in low scores on these PRI subtests. 
Studies that examined the short-term effects of methylphenidate on WISe-III 
have failed to reveal significant methylphenidate treatment effects for subtest, index, or 
VIQ and PIQ scores (Saklofske, et al" 1993; Schwean, et a1., 1993). Profitera, et a1., 
(2005) noted that given the results of studies indicating the lack of medication effects on 
WISe-III performance, it seemed unlikely that the WISe-IV ADHD clinical study that 
included a large percentage of children being treated with medication would reflect 
significant differences in the performance of ADHD children and matched controls. 
However, the standardization sample of the WISe-IV was not separated by medication 
effects, so no inferences can be drawn about the differences in performance between 
medicated and nonmedicated ADHD children. Although this study grouped medicated 
children and nonmedicated ADHD children separately, no attempt was made to control 
for medication type, dosage, release times, and duration of medication use. Despite 
reported large effect sizes for stimulant medication on intelligence scores in the Faraone 
(2003) study, the literature on long-term results of psychostimulants on cognitive 
functioning is sparse. 
The present study found significantly poorer performance among the ADHD 
nonmedicated group than among its matched control on DSF. Hale, Hoeppner and 
Fiorello (2002) found Digits Forwards (DF) and Digits Backward (DB) component 
scores to be differentially predictive of attention, executive function, and behavior rating 
measures. Their results suggest that DB is associated with attention and executive 
function processes more than the short term rote auditory memory tapped by DF. 
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However, these authors note that DB was only modestly related to attention, executive 
function, and teacher rating measures, and not related to parent-reported attention 
problems. 
The findings of the current study are not inconsistent with Barkley's (1998) 
disinhibition model because possible deficits in the executive functions which were 
needed to initiate and monitor peIformance on Digit Span may adversely impact 
peliormance. ADHD children tend to misperceive the cognitive effort required to 
complete tasks, and have difficulty modulating output. Efficient use of executive 
functions enables one to use their cognitive processes more efficiently. The poorer 
performance on DSF than on DSB in these results may be explained by the position of 
DSB in testing (following DSF). Its increased difficulty may serve to cue ADHD 
children to engage their mental processes further in the service of better performance. 
Although the findings of this study with poorer performance of the ADHD 
children on WMI appears consistent with Rapport's (2000, 2001) working memory 
model, which posits that working memory is the core deficit in ADHD, Rapport's model 
is a very poor fit for the discovery of poorer performance on DSF than on DSB, because 
DSB requires much greater involvement of working memory capacities than DSF. The 
poorer peIformance on DSF, than on DSB by the ADHD group in this study may be 
explained by Wu, Anderson, and Castiello's (2002) resource allocation model of ADHD, 
which posits that the poorer performance of ADHD is associated with problems in 
utilizing attentional capabilities in an optimal manner, but is not associated with 
attentional incapacities. 
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Contributions to the Field 
This study was the first that attempted to use verbal ability to match controls to 
ADHD in order to examine issues such as ADHD vs. nonADHD performance, and 
ADHD medicated vs. ADHD nonmedicated performance on factors such as general 
estimates of intellectual functioning, working memory, and processing speed. The data 
collected offer opportunities for further research to answer additional research questions 
about the pelformance of these groups. Although no significant differences were found 
in group mean FSIQ differences between ADHD groups and their matched controls, or 
between medicated groups and nonmedicated ADHD groups, other aspects of test 
performance could be studied. For example, preliminary analyses of the data collected in 
this study suggest that it might be fruitful to examine the differences between the ADHD 
and control groups in terms of the degree of score differences between Verbal 
Comprehension and Working Memory Index scores. 
Children with attentional disorders may be more likely to experience problems 
with working memory, as suggested by significantly lower scores on the Working 
Memory Index. However, it must be a demonstrated fact that this is the case with each 
individual child, rather than becoming an assumption that this applies to all children with 
this diagnosis, thus being used as a diagnostic marker. Parents of ADHD children should 
be made aware of the lack of definitive data on the effects of medication on cognitive 
functioning when they are attempting to make decisions about whether or not to use 
medication as a treatment for their ADHD children. 
In clinical practice, the focus is on individual cases, rather than groups of cases. 
The wide variations in the pelformances both of medicated children and of nonmedicated 
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ADHD children found in this study, even after matching subjects on the basis of verbal 
ability, should serve as caution against overuse of group comparison data to guide 
interpretation of cognitive ability profiles. Interpretations regarding the effects of 
ADHD, and/or the effects of medication use for ADHD on cognitive functioning need to 
be established on a case-by-case basis. 
Limitations 
This study focused on cross-sectional comparisons of group data, rather than on 
longitudinal data for treatment and control groups. For example, it is possible that 
medication effects would be found if an ADHD diagnosed group and a non ADHD 
control group were tested at time 1, and then retested at time 2 after half of the ADHD 
group had begun medication, and the other half had not. Doyle, et a1. (2002) noted that 
further study of ADHD persons before and after the use of stimulant, and other 
medications is necessary to determine the impact of medication on test sensitivity. 
Another limitation of this study is that the method of ADHD diagnosis in this 
study could not be ascertained. The gold standard of diagnosis is considered to be the 
DSM -IV -TR. Handler (2001) noted there are inherent weaknesses in relying solely on a 
clinical classification system for making diagnostic decisions, including issues around the 
use of fixed cut-off points, gender differences in the expression of ADHD 
symptomatology, duration and pervasiveness criteria, and the employment of potentially 
subjective guidelines for diagnosis. 
An additional limitation of this study is that data was collected only on children 
referred for possible learning disabilities. Co-morbid conditions are a confound when 
73 
analyzing their effects on measures of inte11igence. Co-occurring disorders might have 
their own effects on intel1igence, working memory, and processing speed. Additional 
research is needed to examine more closely the cognitive abilities of children with 
concurrent diagnoses of Learning Disorders and ADHD, in particular; separate samples 
of children representing the various subtypes of each disorder is needed. The literature 
suggests that ADHDIIT is a distinct syndrome from other sUbtypes; (Barkley, DuPaul & 
McMurray, 1992), and unlike the ADHD/HIT that pelform at average lQ levels, the 
inattentive subtype negatively impacts cognitive processes. Additional research is 
needed to investigate the effect of sUbtype on cognitive processes. Similarly, gender and 
racial differences were not studied because of the difficulty in obtaining large samples. 
Gaub & Carlson (1997) found greater intel1ectual impairments in girls with this diagnosis 
than in boys with the same diagnosis. Future resem:ch investigating the effects of the 
moderator variables such as gender and race is needed. 
Future Directions for Research 
Future research using a chi square analysis of VCIIWMI split differences may 
reveal more specific cognitive impairments in ADHD children. These impairments may 
not have been shown by the methods and measures used. Examination of the data show 
large differences between VCl and WMl scores, suggesting there is a real difference 
between ADHD children's verbal reasoning ability and ability to hold information in 
short term memory. ADHD children tend to have less working memory capacity relative 
to their reasoning ski11s. The difference scores between VCl and WMl could be 
calculated and examined statistically for group mean differences, or other statistical tests 
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such as chi square analysis could be employed. For example, each group could be split 
into two levels: VCl-WMl fewer than 10 points, and VCl-WMl greater than, or equal to 
10 points. The proportions could then be tested statistically. This test would answer the 
question, "Do more ADHD nonmedicated children have large splits between VCl and 
WMl than medicated ADHD children?" "Do more ADHD children have large VCl 
minus WMl splits than non ADHD children?" Preliminary analysis of the data suggests 
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19500 Bulverde Road, San Antonio, Texas 78259 (herein the "Publisher") and 
NAME: Janet Friedman 
ADDRESS: 9 Gatsby Lane 
Berlin, NJ 08009 
(herein the "Licensee"), WITNESSETH: 
WHEREAS the Publisher is the copyright owner of the 'Vechsler Intelligence Scale for 
Children - Fourth Edition Integrated Technical and Interpretive Manual (herein the 
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WHEREAS the Licensee wishes to use Table 5.30 from the Work(s) for interpreting and 
finalizing Licensee's Doctoral dissertation research results (herein the "Licensed Use"). 
NOW, THEREFORE, the Publisher and the Licensee agree as follows: 
1. 	 The Licensee may either produce, have produced, and/or distribute such reproductions of the 
Work specified above, solely for the Licensed Use and subject to the terms and conditions set 
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Appendix A2 
Table 5.30 (Wechsler, 2003, p. 88) Mean Performance of ADHD and Matched Control Groups 
Subtest! A lIention-Deficit 
Process Hyperactiyity Disordet· Matched Contorl Group Group Mean Comparison 
Score/ Standard 
Composite Mean SD Mean SD N Difference t yalue p yalue Difference" 
BD 9.9 2.9 lOA 2.6 89 OA7 1.39 0.17 0.17 
SI 10.1 3.0 lOA 2.6 87 0.33 0.82 OA2 0.12 
DS 9.6 3.0 10.5 2.9 89 0.98 2.24 0.03 0.34 
PCn 10.5 2.8 lOA 2.7 89 -0.10 -0.25 0.80 -0.04 
CD 8.3 2.5 10.0 2.2 87 1.72 4.95 <.01 0.74 
VC 9.9 2.6 10.9 2.8 87 1.08 2.87 0.01 OAO 
LN 9.3 3.5 10.3 2.8 89 1.00 2.03 0.04 0.31 
MR 9.7 2.9 10.3 2.8 89 0.66 1.87 0.06 0.24 
CO 9.3 2.8 10.3 2.5 87 1.01 2.63 0.01 0.38 
SS 9A 2.7 10.2 2.8 89 0.89 2.17 0.03 0.32 
PCm lOA 3.2 10.7 3.1 89 0.30 0.72 OA7 0.10 
CA 9.1 2.9 9.6 3.0 89 OA9 1.13 0.26 0.17 
IN 9.7 2.8 11.0 2.9 88 1.30 3.35 <.01 OA6 
AR 8.7 3.3 10.8 2.8 45 2.04 3.65 <.01 0.67 
WR 10.1 2.9 10.9 2.7 89 0.85 2.33 0.02 0.31 
BDN 9.9 2.8 10.5 2.6 89 0.58 1.80 0.08 0.21 
DSF 9.6 2.8 10.5 2.8 89 0.83 1.96 0.05 0.29 
DSB 9.6 3.2 lOA 2.8 89 0.76 1.74 0.09 0.25 
CAR 8.7 2.9 9.6 3.0 89 0.90 2.15 0.03 0.30 
CAS 9.5 2.9 9A 2.8 89 -0.13 -0.32 0.75 -0.05 
VCl 99 13.6 102.5 13.2 83 3A3 1.81 0.07 0.26 
PRI 100.1 14.2 102.3 13.0 89 2.15 1.23 0.22 0.16 
WMI 96.1 15.5 101.7 13A 89 5.57 2.52 0.0] 0.38 
PSI 93A 12.6 100.7 12.3 87 7.30 3.88 <.01 0.59 
FSIQ 97.6 14.0 102.7 12.5 82 5.06 2.71 0.01 0.38 
"The Standard Difference is the difference of the two test means divided by the square root of the pooled variance, computed using Cohen's 
(J996) Formula lOA. 
93 
Appendix B 
ADHD Medicated ADHD Medicated Controls 
ID CA Race PED VCI CA Race PEDL VCI 
1000 10 W 5 142 9 W 4 142 
1001 10 W 3 89 10 W 3 87 
1003 11 AA 3 93 10 AA 3 93 
1005 13 W 4 95 14 W 4 96 
1006 12 W 5 140 12 W 5 140 
1007 10 W 3 110 10 W 3 108 
1008 9 W 3 91 9 W 3 91 
1009 13 W 3 91 13 W 3 93 
1010 13 W 3 100 11 W 3 104 
1011 9 W 5 119 8 W 5 119 
1012 10 W 3 100 9 W 3 99 
1013 12 AA 2 96 13 AA 2 93 
1014 10 W 5 106 10 W 5 106 
1015 8 AA 2 89 8 AA 3 87 
1016 9 W 3 96 9 W 3 96 
1017 13 W 5 128 13 W 5 130 
1018 8 W 3 98 8 W 3 99 
1019 12 W 3 85 12 W 3 87 
1020 8 W 3 87 8 W 3 87 
1021 9 W 3 91 9 W 3 89 
1022 8 W 3 99 9 W 3 99 
1023 10 W 3 99 10 W 3 100 
1024 10 W 4 106 10 W 4 108 
1025 10 W 3 106 10 W 3 106 
1026 8 W 3 87 8 W 3 85 
1027 12 W 2 102 11 W 3 100 
1028 13 W 2 96 13 W 2 96 
1029 8 W 5 126 12 W 5 126 
1030 9 W 5 112 9 W 5 114 
1032 12 AA 3. 81 12 AA 3 81 
1033 9 AA 2 95 9 AA 2 93 
1034 12 W 3 98 12 W 3 98 
1035 11 W 3 85 12 W 3 85 
1036 8 W 4 110 8 W 4 110 
1037 9 W 5 99 9 W 3 99 
1038 12 W 3 91 12 W 3 93 
1 039 11 W 3 112 11 W 3 116 
1 040 11 AA 3 91 12 AA 3 91 
1041 13 W 3 126 13 W 4 124 
1042 13 W 3 95 13 W 3 95 
1043 10 AA 3 95 10 AA 3 96 
1044 9 W 4 106 9 W 4 106 
1 045 11 W 5 1 00 10 W 5 100 
1046 12 W 3 91 12 W 3 93 
1047 12 W 3 98 12 W 3 98 
1048 10 W 3 93 11 W 3 93 
1049 10 H 2 85 10 H 2 83 94 
1050 10 W 3 95 11 W 3 96 
1051 10 W 4 99 10 W 4 104 
1052 13 W 5 93 13 W 5 91 
1110 9 W 5 100 9 W 5 100 
1111 9 W 5 130 10 W 5 132 
1112 10 W 3 106 10 W 3 106 
1113 13 W 5 112 13 W 5 112 
ADHD Nonmedicated ADHD Nonmedicated Controls 
1053 11 W 5 128 11 W 5 130 
1054 9 W 5 124 9 W 5 124 
1055 11 W 3 112 10 W 3 112 
1056 13 W 5 126 15 W 5 124 
1057 12 W 3 112 14 W 3 112 
1058 11 W 3 100 13 W 3 100 
1060 10 W 3 134 10 W 5 134 
1061 11 W 2 95 11 W 3 95 
1062 12 W 3 91 11 W 3 91 
1063 12 W 3 81 12 W 3 81 
1064· 8 W 4 95 9 W 4 93 
1065 8 W 2 95 9 W 2 95 
1066 13 W 4 108 13 W 4 106 
1067 12 W 3 91 11 W 3 93 
1068 13 AA 3 95 12 AA 3 95 
1069 9 W 3 100 9 W 3 100 
1070 9 W 4 106 8 W 4 106 
1071 10 W 3 83 9 W 3 83 
1072 11 W 2 104 11 W 2 106 
1073 13 W 5 124 12 W 5 121 
1074 8 W 3 96 8 W 3 95 
1075 9 W 4 98 9 W 4 98 
1076 8 W 2 112 8 W 4 110 
1077 9 H 3 85 9 H 3 83 
1078 11 W 2 104 12 W 2 100 
1079 8 W 5 96 8 W 5 95 
1080 8 W 3 100 8 W 3 100 
1081 9 W 3 91 9 W 3 93 
1082 8 W 3 104 8 W 3 104 
1083 9 AA 3 91 8 AA 3 89 
1084 12 W 3 95 12 W 3 95 
1085 13 W 3 124 13 W 4 124 
1086 10 AA 3 85 10 AA 3 85 
1087 10 AA 3 93 10 AA 3 93 
1088 13 AA 3 102 12 AA 4 104 
1089 13 W 3 112 13 W 3 112 
1090 8 AA 3 83 8 AA 3 87 
1091 8 W 3 104 8 W 3 104 
1092 13 W 3 98 13 W 3 98 
1093 8 W 3 108 8 W 3 108 
1094 8 W 3 98 8 W 3 96 
1095 8 AA 2 81 10 AA 3 81 
1096 11 AA 3 93 10 AA 3 93 95 
1097 8 W 3 87 9 W 3 87 
1098 10 AA 3 89 11 AA 3 91 
1099 13 AA 3 110 12 AA 5 112 
1100 13 W 3 130 13 W 5 130 
1102 8 W 4 116 8 W 4 114 
1103 8 W 5 102 8 W 5 100 
1104 8 H 3 91 8 H 3 91 
1105 11 W 2 91 10 W 2 89 
1106 10 W 3 91 10 W 3 91 
1107 12 W 3 96 12 W 3 96 
1108 13 W 4 102 14 W 4 102 
1109 8 W 5 102 9 W 5 100 
